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ABSTRACT 
MARTIN G. BIALER. Acid Lipase Deficiency and Lipid Storage in Wolman's 
Disease and E60D-Treated Cells in Culture. (Under the direction 
of RUSSELL A. VINCENT, JR., Ph.D). 
Fibroblasts obtained from a child with Wolman's disease and 
maintained in culture demonstrated acid lipase deficiency, reached 
senescence prematurely and exhibited an abnormal #5 chromosome. When 
cyt,ogenetic analysis was repeated on frozen and stored cells, the 
chromosomal defect could no l~nger be demonstrated~ but other anomalies 
were present. The karyotypes of other Wolman's disease cell cultures and 
the parents of the proband were normal. The mother's fibroblasts 
had reduced acid lipase activity, consistent with a carrier-state, but 
the father's fibroblasts had normal acid lipase activity. It was 
possible to classi~y a culture as Wolman's disease, carrier or normal by 
the ability of medium from the culture to reduce the lipid stored in a 
Wolman's disease cell culture. The culture of the proband stored 
more lipid than other Wolman's disease cultures. 
1wo enzymes present in fetal calf serum possessing paraoxonase 
activity could be differenti.ated by their sensitivity to heating at 
56°C. The esterase inhibitor E60D was s~ightly more toxic to Wolman's 
disease than to normal cells, and was also toxic to E. coli. 
Normal cells exhibited lipid storage when treated with lO-4M 
E600, but a more pronounced time-dependent accumulation of lipid 
occurred at lo-1M E600. p-Nitrophenol, the major metabolite of 
E600. had little effect on lipid storage. The amount of lipid stored 
varried directly with the serum concentration and was unaffected 
vii 
by heat inactivation of the serum. Histochemical stains and biochemical 
analyses were performed on cultured fibroblasts. Both Wolman's disease 
and E600-treated cells showed star.age of tr.i&lycerides and cholesteryl 
esters, although one Wolman's disease culture had a normal level of 
triglyceride. The E600-treated cells also showed a large increase 
in phospholipid and small increases in free cholesterol and free fatty 
acid. Wolman's disease cells treated with E600 showed increases 
comparable to the normal E600-treated cells, but no increase of free 
!;~fatty acid was seen. Wolman's disease he terozygotes appeared to have 
normal amounts of lipid. Lipid in Wolman's disease and E600-treated 
cells fluoresced in ultraviolet ~ight. Cholesteryl esters of 
untreated norma.1 cells had more stearic (18 :0) than -oleic (18 :l(9) 
acid, whereas cholesteryl esters in Wolman's disease~ E600-treated 
cells, and fetal calf serum had three times more oleic than stearic 
acid, suggesti.ng that serum lipid was taken up, but not degraded, in 
Wolman's disease and E600-treated cells. 
Three Wolman's disease cell cultures exhibited geneti'C 
deficiency of acid lipase. Normal fibroblasts had acid lipase activity, 
but possessed little neutral lipase activity. Acid lipase activity 
of normal cells was inhibited by E600. 
Wolman's disease cells resembled normal cells by scanning 
electron microscopy_ Except in a perinuclear zone which also had 
not stained with oil red 0 or neutral red, the cytoplasm of E600-
treated cells had numerous bumps which appeared to form ridges along 
the path of actin stress filaments. 
Normal cells treated with free fatty acid or cholesterol, 
and Wolman's disease cells treated with free fatty acid, exhibited 
lipid storage in l~rge) peripheral lipid droplets. Lipid was 
generally stored in sma~let: granules closer to the nucleus in 
viii 
E600-treated and Wolman's disease cells. E600-treated cells showed 
increased numbers of lysosomes by neutral red staining and had increased 
numbers of dense bodies ultrastructurally. The dense bodies of Wolman's 
disease and E600-treated cells sometimes contained lipid clefts which 
probably consisted of cholesteryl ester. The dense bodies accumulated 
colloidal gold, suggesting their identity with secondary lysosomes. .. " . 
Alth~ugh some differences were observed, E600-treated cells resembled 
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· . INTRODUCTION 
The lysosomal enzyme, acid lipase, was first characterized by Stoffel 
and Greten (1) in 1967. The enzyme was first reported in human tissue by 
Patrick and Lake (2) in 1969. In this report, its deficiency in liver and 
spleen of patients with Wolman's disease was causally linked wi.th this dis-
order. 
In Wolman's disease, triglycerides and cholesteryl esters accumulate 
in many tissues of the body. The liver is particularly affected, storing 
so much lipid that it assumes a yellow color. The spleen and gastrointestinal 
tract are also severely affected. Both adrenals exhibit extensive punctate 
calcification, a feature that is virtually pathognomonic of the disease. 
The disease appears to follow an autosomal recessive pattern of inheritance. 
Infants with Wolman's disease. usually present with vomiting or diarrhea 
and steatorrhea within the first few weeks of life. At this time, 
hepatosplenomegaly is already present,·becom~g massive as the disease 
progresses. The infants ShOll severe malabsorption and fail to thrive. 
Patients have not benefited from the few attempts at dietary management, 
and generally die before six months of .age. Comprehensive reviews of 
Wolman's disease have been wri1;:ten by Patrick and Lake (3) and by Sloan 
and Frederickson (4). It is a severe disorder of lipid storage, an 
indication of the importance of the acid lipase enzyme to normal function. 
Its severity may also be related to the high concentration of triglycerides 
and cholesteryl esters in the body and the continual ~rnover of these 
substances. Thus interference with one step in the metabolic pathway 
may lead to rapid and excessive storage of lipid. 
2 
Cholesteryl ester sto~age disease is another rare disorder, of lipid 
metabolism that appears to be caused by a deficiency of acid lipase (5,6). 
BC7tiever t the disease is generally less severe than Wolman's disease. Many 
patients have shown no symptoms other than hepatosplenomegaly and 
hypercholesterolemia, altho,ugh in some families the disease may have a 
more malignant course leading to death in childhood (7). Altho.ugb cells 
from patients with cholesteryl ester sto~age disease have more residual 
acid lipase activity than those from patients with Wolman's disease (5,8), 
the differences have not been deemed to be sufficient to account for 
the dramatic difference in the courses of the two disorders. However, 
Goldstein II ale (9) have shown that intact cells from patients with 
cholesteryl ester storage disease, which have stored· approximately three 
times as mucbcholesteryl ester as cells derived from normal individuals, 
show nearly one-third the acid lipase activity of normal cells. The same 
cells exhibit only 5% of normal activity when assays are carried out on 
cell-free extracts. Similar studies with intact Wolman's disease cells 
have not been done. Thus, a small difference in acid lipase activity 
when only a small amount of activity is present may make a big difference 
in the amount of ljpid stored and the course of the disease. Brown et ale 
(10) have shown that only 10% of normal acid lipase activity may be 
necessary for normal function. 
The acid lipase enzyme has a pH optimum of approximately 4 to 5 in 
most assay systems (9,11-15). It is active toward both triglycerides 
and cholesteryl esters (15), hydrolyzing both lipids at their ester 
linkages. The enzyme is probably identical to acid cho1esteryl esterase 
·'(15) and acid esterase (13). It 1s relatively resis taRt to E600 
3 
(diethyl p-nitrophenyl phosphate, paraoxon), which allows it to be 
classified as an A-type esterase (16,17) because lipases are considered to 
be a subtype of esterases (18). It is resistant to diisopropylfluorophos-
phate, activated by Triton X-lOO and taurodeoxycholate and inhibited by 
cyanide, p-hydroxymercuribenzoate, sodium chloride, 4,4'-diethylamino-
ethoxyhexestrol, chloroquine and other substances (11,12,14,19,20). 
Acid lipase is a true lipase because it is more active toward esters of 
1~ng chain fatty acids than esters of short chain fatty acids (13,17). 
The enzyme is fairly labile and this has made it difficult to purify 
',(12,13). Cortner.!! al. (8) have separated three bands of acid lipase 
ac~ivity by cellogel electrophoresis, only one of which was absent in 
Wolman's disease and cho1esteryl ester storage disease. Four discrete 
bands of acid esterase activity have been separated by isoe1ectric 
focusing on polyacrylamid~ gel (13,21). Wolman's disease fibroblasts 
I were unable to hydrolyze the substrate used to assay acid esterase 
activity (13,21). It is possible that the isozymes may have different 
substrate specificities (8). 
Acid lipase can be shown to be important to normal function, but 
neither Wolman's disease nor cho1esteryl ester storage disease is very 
important epidemiologically. Tnere have been approximately 30 cases of 
Wolman t s disease reported since it was first described :in 1956 (3,8). 
Cholesteryl ester storage disease has been observed in about 14 patients 
since its first description in 1966 (7).· However, the study of Wolman's 
disease has pointed out the clinical importance of acid lipase activity 
and the study of acid lipase deficient cells has contributed to an 
understand~ng of the way lipid is metabolized and stored in the body. 
4 
Ather9sclerosis is a disease' characterized by plaques of lipid 
material accumulating in the arterial wall. Much of this lipid is 
cholesteryl ester, and in two animal model systems the cholesteryl ester 
bas been shown to accumulate in lysosomes of aortic smooth muscle cells 
(22-24). Several reports have suggested that a relative deficiency of 
acid lipase may be involved in the pathogenesis of atherosclerosis (22-26). 
E600 has been used extensively to inhibit esterases in biochemical 
(27,28) and histological (16,29) studies. Aldridge (27) used the 
sensitivity of esterases to E600 to distinguish between A and B-type 
esterases. B-type esterases are inhibited by lO-SM E600 whereas A-type 
e~terases are not inhibited by IO-3M E600. B-type esterases include 
acetylcholinesterase (27) and liver microsomal esterase (28). A-type 
esterases include acid lipase (16) and serum paraoxonase (30-32), a 
serum enzyme that is able to cleave E600. E600 appears to inhibit 
esterases by transferr~ng a diethylphosphoryl radical to the active 
site (33). Although E600 has been in use as an esterase inhibitor 
since 1950 (34), it has rarely been used to treat whole cells. The few 
studies on whole cells have been toxico~ogical (35,36) or concerned 
with acetylcholinesterase activity of chick embryo muscle cultures 
(37,38). No studies of the effect of treating cultured cells with an 
esterase inhibitor for several days have been published. 
In this dissertation, the results of decreased acid lipase 
activity i~ genetically deficient Wolman's disease cells and in normal 
cells rendered dysfunctional for acid lipase by E600 treatment are 
presented. 111e dissertation consists of a general introduction, four 
research sections t and an overall discussion bringing together all the 
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f1nd~ngs from which certain conclusions are drawn •. The first . research 
section presents an unusual case of Wolman's disease and studies on 
both the parents and the proband. The second research section 
presents evidence that E600 treatment induces lipid s tor,age in normal 
cells and .provides a histochemical comparison of the lipid stored in 
Wolman's disease cells with that stored in E600-treated normal and 
Wolman's disease cells. The third research section presents biochemical 
studies of Wolman's disease and E600-treated cells, including lipid 
analyses and enzymatic studies. In the fourth research section, the 
ultrastructure of Wolman's disease and E600-treated cells is compared 
and electron microscopic cytochemical studies are presented. 
Some results from the first section have been published as an 
abstract in Laboratory Inves~igations (39). Some results from the 
second section have been published as an abstract in the Journal of Cell 
Biol,ogy (40). Data from the second and third sections have been 
submitted to Experimental Cell Research. Early results from the fourth 
) 
section were presented at the Southeastern Electron Microscopy Society 
Meeting (41). 
RESEARCH SECTION I 
Introducti'!! 
Wolman's disease appears to be an inherited disorder with an 
autosomal recessive mode of transmission. Females are affected as often 
as males. Of 15 families studied, first cousin marriages were involved 
in three families, and sibl~gs of the proband were affected in at least 
four (3). Furthermore, parents of affected children and some of the 
8ibl~ngs of affected children have levels of acid lipase activity about 
half that of. normal individuals, falling into the range expected for 
. heterozygotes or carriers of a given trait (3,8,17 ,42). Carriers for 
Wolman's disease can thus be detected by assay of acid lipase activity. 
Fibroblasts cultured from Wolman's disease patients exhibit acid 
lipase deficiency (8,19,42,43) and accumulate tz:ig1ycerides and choles teryl 
esters (42). The lipid can be visualized by staining with oil red 0 (8,42). 
Kyrialddes !:! a1. (42) reported increased lipid storage in fibroblasts 
cultured from the father of a Wolman's disease patient, but this result has 
not been repeated. 
Cultured fibroblasts have been shown to release lysosomal en~es 
into the medium and to take up the enzymesagatn by a specific receptor-
mediated endocytosis (44,45). Cells lacking a specific lysosomal enzyme 
are able to take up that enzyme if it is introduced into the medium. If . 
medium from normal cells, in which acid lipase can be detected (10), is 
added to Wolman's disease cells, the acid lipase is endocytosed and 
transported to lysosomes, where it is able to degrade stored 
tr,iglycerides and ~holesteryl esters. Thus medium fran normal cells 
can be used to correct the Wolman's disease defect ~n vitro (10,42). 
7 
Cy~ogenetic analysis has only been reported on one Wolman's disease 
patient (46), and this patient had a normal chromosome complement. 
Cytogenetic abnormalities are rarely seen in patients with lipid storage 
disorders. This section presents a case of Wolman's disease in which a 
chromosomal anomaly was observed, and includes studies done on the parents 
of this child to provide information about the inheritance of the defect. 
Materials and Methods 
Cell Culture: 
-
2 Cells were routinely cultured as monolayers in 25 cm 
polystyrene tissue culture flasks (Falcon or Corn~ng). They were grown 
in S'ml of ~agle's Mdnimal Essential Medium ~) with Earle's salts (Flow) 
or Dulbecco's modified MEM (GIBCO). The medium was supplemented with 8% 
or .15% fetal calf serum (FCS) (GIBCO) and 1% antibiotic-antimycotic lOOX 
mixture (GIBeO). The same media supplemented with 3% FCS were used for 
cell maintenance. Medium was filtered sterilized through 0.22 }lm cellulose 
acetate filters (~1illipore). Medium was changed weekly. Cells were 
incubated in a tissue culture incubator (WEDeO) at 37.SoC in a humidified 
atmosphere of 5 to 8% CO2 • Manipulations requiring sterile' condi tions 
were carried out in vertical laminar flow hoods (Baker Co.) For 
subcultivation, cells were rinsed with 2.5 ml of pH 7.0, Puck's balanced 
salt solution (PBS) (NaC!, 145.4 roM; Na2HP04 , 845.3 ~M; NaH2P04 , 362.3 VM) 
and exposed to 1.5 ml of pH 7.1 trypsin solution (DIFCO) (0.25% trypsin 
with NaCl, 136.9 roM; Kel, 5.4 roMj dextrose, 5.6 mM; NaHC03 , 7.1 mM; EDTA, 
537.3 ~M) until cells detached. Medium was then added, and the cells were 
transferred to new culture flasks. 
Cell Origin: Fibroblast cultures derived from Wolman's disease patients 
(G~1606J GM-2211), normal donors (GM-179, GM-316, GM-37, GM-498, IMR-90), ' 
a Wolman's disease heterozygote (GM-212l), and a Olediak-Higashi syndrome 
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patient (GM-~075) were obtained as monolayers from the Institute for 
Medical Research (Camden, N.J.). Other cultures (GM-2109, GM-2520, SaJo, 
GM-3557, G~3558, JoAI) were established from skin biopsy specimens. 
GM-2109 (P), a Wolman's disease culture, was established by J.F. Rogers 
from abdominal skin obtained 2 hr postmortem. The other cultures were 
established from forearm biopsies: GM-2520from a 10 year old girl with 
Bloom's syndrome, JoAl from a 13 year old boy with metachromatic 
leukodystrophy, SaJo from a 20.year old normal woman, GM-3557 (M) from the 
24 year old mother and GM-3558 (F) from the 28 year old father of the child 
-from whom culture GM-2109 (P) was established. The latter three cultures 
were established with the help of J.F. Rogers. The skin was cleansed and a 
local anesthetic was applied. A piece of skin was excised with a sterile 
scalpel and placed in sterile medium with antibiotic. The biopsy specimen 
was then cut into fragments approximately 0.5 mm in size and each was 
2 positioned with 4 or 5 other f~agments in one of several 25 cm tissue 
culture flasks. Two and one-balf ml of medium was added to the top 
surface of each inverted flask and the biopsy fragm.,ents were allowed to 
attach to the bottom for 1 hr at room' temperature. Each flask was then 
carefully turned right side up and the medium was allowed to cover slowly, 
but not loosen, the fx:agments. The flasks were incubated at 37.5 °c as 
mentioned above. When o~tgrowths covered about 75% of the flask, the cells 
were subcultured. ,The resultant f ibroblas t cultures were designa ted 
subculture 1. Further subcultures were noted and the pass,age level of the 
cells was recorded for all experiments. 
Cytogenetic analysis: Chromosomes were examined from fibroblast cell 
cultures of Wolman's disease (GM-2109 cP), GM-22l1, GM-1606) and the 
9 
parents of the local proband (GM-3557 (1), GM-3558 (F». Chromosomes from 
lymphocytes cultured from the parents were also examined. Fibroblast 
cultures were treated with colchicine (Lilly) for 3 to 5 hours, swelled in 
hypotonic solution (.075 M KCl) for 35 minutes and fixed in 3:1 methanol-
acetic acid. Lymphocytes were treated with colchicine for 1.5 hours, 
hypotonic for .25 minutes, and fixed similarly. The cells were spread on 
slides and burst by air or blaze drying. The slides were stained with 4% 
Giemsa (Fisher) in pH 6.B phosphate blttfer. For chromosome banding, slides 
were treated with 2 ml of pancreatin (GIBCO) in 7 m1 of Hank's balanced salt 
"solution (GIBCO) and 7 ml of distilled water for 5-6 sec at 37°C. 
Chromosomes were counted and examined from at least 20 cells per 
culture. Karyotypes were prepared on several of the best typical cells and 
an any atypical cell. The initial karyotypes of GM-2l09 (P) were prepared 
under the direction of J.F. Rogers. 
Acid lipase assay: Cells were assayed for acid lipase activity by the 
fluorometric method of Cortner et ale (B). Generally cells were grown to 
confluency in a 75 cm2 flask and trypsinized about one week later. The 
cells were washed three times in PBS, pelleted and frozen at -70°C until the 
time of assay. Substrate, 4-methylumbelliferyl oleate (Research Products 
.. International) dispersed in lecithin (Sigma) and taurodeoxycholate (Sigma), 
was prepared beforehand and frozen. On the day of assay the substrate was 
thawed and one volume was diluted with 7 volumes of 0.2 M acetate buffer, 
pH 4.0. Eight ml was placed into 25 ml Ehrlenmeyer flasks. Four-
methylumbellifercne standards were prepared at concentrations of 0.1 to 
2.0 nmol/ml. Then PBS was added to the cell pellets and they were sonicated 
on ice with a microtip sonicator (Heat Systems - Ultrasonics). Centrifuging 
at this point could increase the measure of activity. but might also 
10 
decrease the reproducibility of the assay. One hundred ~l of enzyme source 
was added to a prewarmed Ehr1enmeyer flask of substrate, mixed, and 
incubated in a 37°C water bath. At 2, 4, 8 and 16 min, 2 ml of reaction 
mixture was removed and read on an Aminco-Bowman spectrofluorophotometer 
at an excitation wavel~ngth of 322 nm and an emission wavelength of 
448 nm. Protein concentration in each sample was measured the next 
day by the method of Lowry II a1. (47) or Bradford (48). The specific 
activity of acid lipase was expressed as nmol of substrate hydrolyzed 
per min per ,mg protein. 
Correction by conditioned medium: To test the ability of medimn from 
different cell lines to correct the Wolman's disease defect, GM-1606 
Wolman's disease cells were seeded onto 22 x 22 mm coverslips in 35 x 10 mm 
4-
culture dishes at a concentration of 5 x 10 cells per dish. Treatment 
with conditioned medium was begun 3 days later and lasted 2 weeks. The 
conditioned medium, with 3% FCS, was pipetted from various cultures~ and 
1 m1 was added to 2 m1 of fresh medium, with 8% FCS. Medium was changed 
'every 3 days and conditioned medium was made up fresh each time. After 
2 weeks, the cells were fixed for 2 hr in calcium buffered formalin 
(4% formaldehyde from paraformaldehyde and 2% calcium acetate, pH 
7.0-7.2). The coverslips were stained with oil red 0 and hematoxylin (49) 
and mounted on slides wit~ glycero~ gel. One hundred cells on each 
coverslip wer~ graded from 0 to 3 in intervals of 0.5 for the extent of 
sudanophilic granulation. Briefly, grade 0 represents no lipid" grade 3 
represents 100% of the cytoplasm exhibiting lipid staining and grade 1.5 
represents 50% of the cytoplasm staining. Cells exemplifying the 
different grades are shown in Figure I. After grading, the numbers were 
summed to give a representation of the amount of lipid present on a 
liven coverslip. 
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Enzyme addition: Coverslip cultures of GM-1606 were prepared as in the 
correction by conditioned medium experiment. The cells were treated with 
vary~ng concentrations of porcine pancreatic lipase (Sigma L-2253), hog 
liver carboxyesterase (Sigma E-9627) or bovine pancreatic cholesterol 
esterase (~igma C-3766) and Sendai virus (103 parti~les per culture 
dish) to increase permeability of the membrane. After 3 days, the 
cells were fixed, stained, and graded as in the correction by conditioned 
" medium experiment. 
Results 
Case Report: 
Following a normal delivery. the proband had diarrhea dur~ng his 
~irst three weeks at home. At 3 months, the child was admitted to the 
Medical University Hospital with massive hepatosplenomegaly and abdominal 
distension. No pre-beta or alpha lipoprotein activity was seen by 
electrophoresis. A liver biopsy showed marked fatty change with massive 
periportal fibrosis. A flat plate of ·the abdomen revealed bilateral 
punctate calcification of the adrenals, virtually pat~ognomonic of 
Wolman's disease. The patient died at .age 4 months. Autopsy revealed a 
malnourished black male infant. There was enlargement of the liver) 
spleen, adrenals and lymph nodes. The liver appeared yellow-orange in 
color Bud microscopic examination revealed fat vacuoles in hepatocytes 
and cholesteryl ester clefts in periportal macrop~ges. Lipid analysis 
revealed increased t~iglycerides, choles teryl es ter, and free 
cholesterol. The presentation was typical of Wolman's disease, the 
first case reported in a black child. 
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cytogenetic Analysis: 
Karyotypes of the GM-2l09 (P) Wolman's disease cell culture 
established from the proband revealed a l~ng B-group chromosome (Fig. 2) 
which, from banding, appeared to be the US chromosome (Fig. 3). The 
l~g chromosome was present in 19 of 21 cells examined, and the 2 cells 
in which it was not seen were very contracted and difficult to analyze. 
lCaryotypes from the GM-1606 (~ig. 4) and GM-22l1 (Fig. 5) Wolman's 
disease cell lines revealed normal female and male karyotypes 
respectively_ Karyotypes from GM-3557 (M) (Fig. 6) and GM-3558 (F) 
(~ig.· 7), cell cultures established from the parents of the proband, 
~evealed no balanced translocation or other abnormality, and the banded 
kaxyotypes (~igs. 8,9) did not reveal the presence of a condition 
(e._g. an inversion) that ~ight dispose the proband to a translocation 
event. 
Cells that had been frozen and stored at the Institute for 
.Medical Research were utilized to repeat cytogenetic analysis on the 
G~2~09 (P) culture. The cells grew poorly and only 10 metaphase 
cells were obtained. Of these, 7 were normal, 2 showed a different 
abnormality of the #5 chromosome (5p+) and 1 cell showed a partial 
duplication of the #1 chromosome. No cells showed the anomaly 
seen initially. 
Acid lipase assay: The cells of the proband showed a deficiency of acid 
lipase that was comparable to the 2 other Wolman's disease cell cultures 
assayed (Table 1). 
If this case followed classical Mendelian inheritance, both 
parents would be expected to be carriers for the disease and the 
TABLE 1 
ACIn LIPASE ACTIVITY OF CELL HOMOGENATES PREPARED FROM CULTURED 
CELLS OF CLINICALLY NORMAL AND WOLMAN'S DISEASE DONORS.a 











GM-2109 (proband) 0.29 
Mean 0.34 + 0.10 
8Confluent cell cultures were trypsinized, pe11eted, and 
sonicated on ice on a microtip sonicator. Homogenates were 
assayed for acid lipase by a fluorometric technique. 
bNanomoles of 4-methylumbelliferyl oleate hydrolyzed per 
min per mg protein. 
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chromosomal anomaly would be unrelated to the disease process. However, 
when acid lipase was assayed, only the mother (GM-3557 (M» appeared to be a 
carrier for Wolman's disease (Table 2). The father (Glf-3558 (F» had a 
normal level of acid lipase activity. Although this assay is somewhat 
variable, the mother could be classified as a-carrier in 2 of 3 assays 
tho,ugh appeari,ng normal in one assay and the father could be classified 
as normal in 3 of 3. 
Correction by conditioned medium: Media from. normal ce11 cultures and 
a Chediak-Higashi cell culture caused a reduction of lipid storage in 
Wolman's disease cells (Fig. 10), thus demonstrating the ability to 
correct the Wolman's disease defect. Media from Wolman's disease cells 
showed little correction. Medium from a known carrier for Wolman's 
disease showed some ability to correct the defect but not as much as 
seen in media from normal cells. Media from the parents of the local 
proband were also examined. Media from the father's cells corrected the 
defect as well as normal cells whereas media from the mother's cells 
did not. All the results correlated well with the level of acid lipase 
activity of the different cultures, providing further support for 
classifY~ng the mother, but not the father, as a carrier for Wolman's 
disease. When the extent of lipid in the treated cultures was plotted 
,against the acid lipase activity shown in assay 1 of Table 2, the points 
fit a straight line (Fig. 11), statistically s,ignificant by linear 
regression (p<.05). 
Cells from the parents exhibited little oil red 0 staining whereas 




ACID LIPASE ACTIVITY OF CELL HOMOGENATES PREPARED FROM CULWRED CEu..S 
OF CLINICALLY NORMAL. WOLMAN'S DISEASE AND WOLMAN'S DISEASE 
HETEROZYGOTE DONORS, AND OF THE PARENTS OF THE PROBAND. 
SAMPLE 
Assay 1 Assay 2 Assay 3 
Apparently normal: 
GM-179 2.49 2.58 1.00 
GK-37 2.28 2.59 1.10 
GM-498 1.04 2.77 1.06 
GM-2075 1.87 5.17 2.50 
GM~2520 1.29 1.68 <1.96 
GM-1492 1.52 
GM-1493 5.43 
JoAl 1.85 1.88 
GM-316 1.24 
Mean 1.79 ± 0.62 2.95 ± 1.52 1.53 + 0.58 
Wolman's disease: 
GM-1606 0.16 0.17 0.12 
GM-2211 0.41 0.29 
Mean 0.29 ± 0.18 0.21 ±. 0.12 
Carrier: 
GM-2121 1.08 1.00 
Proband's parents: 
CM-3551 (M) 0.96 2.87 0.57 
GM-3558 (F) 2.28 3.13 2.22 
~anomoles of 4-methylumbelliferyl oleate hydrolyzed per min per mg 
prote~n. 
~igure 1. Cytoplasmic lipid accumulation in cultured 'cells 
showi,ng th~ grades (0-3.0) into which cells were classified according 
to the extent of oil red 0 positive staining they exhibited. Stained 







-f~gure 2. Karyotype of the GM-2109 (P) cell culture derived 
from a child with Wolman's disease. The male karyotype exhibited 
extra material on the l~ng arm of a B-group chronnsome (arrow). 
Stained-with Giemsa. 
~igure 3. B-group chromosomes of Wolmants disease cell-culture 
GM-2109 (P) stained by a Giemsa banding procedure. The chromosome with . -
the l~ng arm appeared to be the #5 chromosome. The karyotype of -the 
G~2109 (P) culture was 46,XY,5q+. 
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~igure 4. Karyotype of Wolman's disease cell culture. GM-1606. 
Metaphase spreads from this culture exhibited a normal female karyotype 
(46,XX). Stained with Giemsa. 
~igure 5. Karyotype of Wolman's disease cell culture GM-2211. 
Metaphase spreads from this culture exhibited a normal male karyotype 
(46,XY). Stained with Giemsa. 
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~igure 6. Karyotype of the GM-3557 cell culture, derived from 
the mother of the proband (GM-2l09). Metaphase spreads from this 
culture exhibited a normal female karyotype (46,~{). Stained with 
Giemsa. 
~igure 7. Karyotype .of the GM-3558.cell culture, derived from 
the father of the proband (GM-2109). Metaphase spreads from this 
culture exhibited a norm~l male karyotype (46,XY). Stained with Gie~sa. 
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~igure 8.- Giemsa-banded karyotype of .the GM-3557 cell culture, 
derived from .the mother of the proband (GM-2109). The karyotype 
appears normal. 
~igure 9. Giemsa-banded karyotype of the GM-3558 .cell -culture, 






































F,1gure 10. Correction by conditioned medium •. Cells from the 
G~1606 Wolman's disease culture, -which normally.stores lipid) were 
grown for 2 weeks in the presence of conditioned media from other cell 
cultures. (A) Fresh medium; (B) GM-1606, Wolmanfs disease; (e) GM-2121, 
Wolman 18 disease heterozygote; CD) GM-179, normal; (E) G~1-3557, mother 
of. proband; (F) GM-3558, father of proband. Stained with oil red .0 . 
and hematoxylin. X350. 
~igure 11. Correlation of the extent of correction of lipid 
sto~age in GM-1606, Wolman's disease cells treated with conditioned 
media from other cell cultures with the acid lipase activity of those 
cell cultures (Assay 1 of Table 2). One hundred cells per point were 
graded for the extent of oil red 0 positive granulation according to 
the grades shown in ~ig. 1 and the numbers were sumned to give the 
ordinate value. The line was statistically significant by linear 
~egression (p<.05). 
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Figure • Cytoplasmic lipid accumulation in s cultured 
a patient with WolDIan' s disease and his parents. (A) GM-3558, 
the proband; (B) GM-2l09, Wolman's disease proband; 
(C) GM-3557, mother of the proband. Significant accumula 





Enzyme addition: Wolman's disease cells treated with lipase (0.2, 0.02, 
0.002 ~g/ml), esterase (0.2, 0.02,0.002 .mg/ml), and cholesterol esterase 
(0.4, 0.04, 0.004 .mg/ml) showed no difference in lipid stor.age from 
untreated cells. 
Discussion 
The initial cytogenetic find~ngs, obtained when the cells were 
actively proliferati.ng, s~ggested that the karyotype of the proband 
contained a translocation onto the long arm of chromosome 115 (46,XY,5q+). 
Cyt.ogenetic and b1ochem~cal studies of the parents were undertaken in 
order to elucidate the possible relation between a chromosomal anomaly 
and the inheritance of a lipid sto~age disease. Results of acid lipase 
assays and conditioned media addition experiments indicated that, though 
the mother appeared to be a carrier for Wolman's disease, the father 
appeared to have a normal level of acid lipase. This focused attention 
on the father, because without deletion of his normal acid lipase gene 
the child would not have been' expected to exhibit the symptoms of 
Wolman's disease. The father's karyotype did not show a balanced 
translocation nor was there evidence of an inversion or other 
rearrangement that could have disposed the proband to a translocation 
event. The results could be explained by a translocation during meiosis 
of the germ cells of the father or during an early mitotic division of the 
~gote. Cells from ~he proband had been submitted to the Institute for 
Medical Research for ultracold storage. During the course of the studies, 
we encountered difficulties in recovering a proliferative culture from 
storage, presumably due to the early senescence of the culture. After 
approximately 10 attempts, a proliferating culture was obtained and the 
cytogenetic ~alyseswererepeated. On this occasion" no cells showed the 
5q+ anomaly and, alth~ugh two cells showed. other rearrangements involving 
chromosome lIS, seven cells appeared normal. The cells still stored lipid. 
These results raise the possibility that the initial cytogenetic finding 
did not truly reflect the karyotype of the proband. 
Alth~ugh the karyotypes of cultured human fibroblasts are usually 
stable and diploid (50,51), it is possible for clones with marker 
chromosomes to emerge in culture (52,53). Even though the aberrent 
chromosome was present in at least 90% of the metapbasesexamined, it 
remains possible that in a poorly proliferat~ng culture the population 
could become enriched by selection for clonally derived cells with increased 
proliferative capaci ty and an associated cYt':0genetic anomaly. If the 
proband had a normal karyotype, the father should have been a carrier for 
Wolman's disease. His apparently normal level of acid lipase activity may 
have been a false negative due to individual variation~ in acid lipase 
a.ctivity and variation in the, assay. If this is true, further cases of 
Wolman's disease may appear in this family. If the proband were not the 
. . 
son of the presumed father, the true father could stil1 be a carrier or his 
karyotype could contain a balanced translocation. The possibility that this 
case of Wolman's dise'ase followed an X-linked recessive mode of inheritance 
cannot be ruled out. However, few diseases normally inheri ted autosomally 
can be inherited as X-lined recessives (54,55). The fact that only one 
. gene product appeared to be affected favors the hypothesis that the 
karyotype of the proband was normal because most chromosome aberrations 
result in multiple developmental an~malies. 
In favor of the linkage of the acid lipase defect to the 
cyt,ogenetic anomaly were the normal level of acid lipase in the fa ther and 
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the presence, of the cyt,agenetic anomaly in the cells of the proband before 
ultracold storage and the manifestation of senescence. The GM-2109 (P) 
culture reached senescence after only 18 population doublings (Research 
Section II), and senescent cultures characteristically exhibit increased 
aneuploidy and tetraploidy (56). The effects of senescence, lipid storage, 
and freez~ng on the emergence of karyotypically distinct cells are unclear 
at this time. It is possible that an initial translocation which deleted 
the acid lipase gene was susceptible to further genetic rearrangement 
and was lost. In this, case, alth~ugh the cells might appear to have a 
normal chromosome complement, a small deletion might still be present. A 
deletion from the q terminal end of chromosome U5 wou1d be consistent with 
the initial cytogenetic findings. If the acid lipase gene were located in 
this region, it might exhibit l~age with diphtheria toxin sensitivity, a 
marker which has been localized to the 5ql5~5qter region (57). If Wolman's 
disease was caused by the translocation in this case, future children in 
this family would not be expected to inherit Wolman's disease. 
. No final conclusions about the inheritance of this case of Wolman's 
disease can be drawn. If the couple should have another child with 
Wolman's disease, it would appear likely that the chromosomal anomaly was 
an artifact of tissue culture. . If the acid lipase gene is mapped to 
chromosome US it would appear likely that the proband had a chromosomal 
aberration and the other conclusions discussed above would follow. 
Mapping experiments on acid lipase are currently being conducted by other 
laboratories (P. Coates, personal communication). 
The enzymes (lipase, esterase, cholesterol esterase) added to the 
Wolman's disease culture should have been able to degrade some of the 
stored lipid •. The fact that they did not s,uggests that the enzymes 
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. did not reach the lysosomes where the lipid was stored, or that their pH 
optima differe~ greatly from the lysosomal pH, resulting in minimal 
enzyme activity_ It is also possible that the enzymes were unable to enter 
the cell. The activities of the enzymes were not Checked prior to their 
use, so the possibility that a loss of activity had occurred cannot be 
ruled out. 
It is difficult to evaluate the effect lipid storage may have had 
on cell .ag~ng or karyotypic instability in the GM-2l09 (P) culture, but it 
is possible that lysosomal neutral lipid sto~age may have more profound 
effects on cultured cells than is currently believed. 
RESEARCH SECTION II 
Introduction 
The esterase inhibitor, E600 (diethyl p-nitrophenyl phosphate), is 
an extremely toxic substance. It has been employed as a pesticide under 
the trade name paraoxon. Parathion, the sulfur analogue of E600, is still 
in wide use as a pesticide. In the insect's body, the parathion is 
oxi.dized to E60D, which blocks acetylcholinesterase activity and 
ultimately' kills the insect (36). Although E60D is much more toxic to 
whole animals than either parathion or the hydrolysis product of E60D, 
p-nitrophenol, the toxic relationships may be reversed in cultured cells. 
Both parathion and p-nitrophenol are more toxic to BeLa cells and fibro-
blasts than E600 (36), tho.ugh this result was not seen in chick embryo 
muscle cells (38). 
As mentioned previously, E600 has been used to differentiate 
between B-type (E600-sensitive) esterases and A-type (E600-resistant) 
esterases (27). Although E600 appears to inactivate most esterases by 
phosphorylat:i:ng the enzymes at their active site, an A-type esterase 
present in mammalian sera which binds normally can remain active, 
presumably by releasing the phosphoryl group, thus catalyzing the 
hydrolysis of E600 to p-nitrophenol (30). This esterase or "paraoxonase" 
activity of mammalian sera has been much studied (30-32,58) and can be 
reduced by the use of inhibitors such as EDTA and aluminon (31) or heat 
inactivation (32). 
This section presents evidence that treating fibroblast cultures 
with E600 induces lipid storage in the cells. Different parameters of 
E60o-induced lipid storage, including dose and time dependence, origin _ 
28 
of the lipid., and histochemical characterization of the lipid are shown. 
Other histochemical data will be presented to compare lipid storage in 
different Wolman's disease cell lines, to compare the effect of adding 
various lipids to normal and Wolman's disease cell cultures, and to 
determine the effect of E600 treatment on neutral red granules. The 
effect of E600 on bacterial cultures is also shown. 
Materials and ~£thods 
E600 Treatment: Stock solutions of E600 (S.igma Chemical Co.) were prepared 
in 100% ethanol at 200X the desired final concentration. Treated cells 
received 0.5% of the stock solution. Controls were treated with 0.5% 
ethanol, a concentration which is reportedly not harmful to cultured cells 
(35) and appeared to have no effect on lipid storage. In th~ growth 
curve experiment, the E600 was carried in 1% ethanol. Cell cultures were 
usually exposed to E600 1 to 4 days after seed~ng. Stock E600 was added 
to fresh medium shortly before each c~nge of medium. 
Paraoxonase Inactivation: Fetal calf serum (FCS, GIBCO) was pipetted into 
cle~n sterile plastic test tubes and heated at 56°C or 70°C in a water bath 
or subjected to gamma radiation in a ·gammator (Isomedix, Inc.) for specified 
periods. 
, -3 
HEM without phenol red (GIBCO) but contain~ng 10 M E600 was prepared 
with 3% FCS, 8% FeS, and 15% FCS for each inactivation time. Controls 
lacki.ng serum or E600 were prepared. Tubes with 5 m1 of the different 
media were incubated at 37°C for 4 days and the p-nitrophenol formed by 
the hydrolysis of E600 was assayed according to the method of Aldridge 
(30). p-Nitrophenol was extracted with 5 ml of n-butanol-toluene (1:1). 
From the upper layer, 2.5 ml was drawn off and 1.5 ml of 20% ammonium 
qydroxide 1n 100% ethanol was added to it. The volume was adjusted to 
5 m1 with approximately 1 m1 of n-butanol~ toluene. The absorbance of 
the samples was read on a Gilford spectrophotometer at a wavelength of 
420 nm. p-Nitrophenol standards were prepared in medium and treated 
similarly. The concentration of p-nitrophenol in each sample was calculated 
from the linear ~egression of the standard curve. 
Growth Curve: Normal fibroblasts (GM-179 or SaJo) and Wolman's disease 
fibroblasts (GM-2l09 (P) or GM-l606) were seeded into 35 x 10 mm culture 
dishes at a concentration of 5 x 104 cells per dish. No less than 24 
hr later, treatment with different concentrations ·of £600 was begun. 
At this time 3 culture dishes for each culture were trypsinized and 
counted in a hemocytometer. At days 2, 4, 8, 12 and 16, 3 culture dishes 
each for untreated normal, treated normal, untreated Wolman's disease, and 
treated Wolman's disease cultures were trypsinized and counted in a 
hemocytometer. A trypan blue viability stain (59) was performed on every 
culture counted. The counts for the 3 cultm'e dishes were averaged, 
. givi:ng one value + standard deviation that represented the ntmlber of 
cells in a given culture on'~ given day. 
Relative Toxicity: Normal fibroblasts (GM-179) and Wolman's disease 
fibroblasts (GM-1606) were seeded into 35 x 10 mm culture dishes at a 
concentration of 5 x 104 cells per dish. After 24 hr the cells were 
treated with vary~ng concentrations of E600 (4 x lO-1K~ 2 x IO-3M, IO-3M, 
-4 -4 5 x 10 M, 10 M, none) in HEM supplemented with 15% PeS. At 2 days and 
6 days, 3 culture dishes per E600 concentration were trypsinized and 
counted, and the counts were averaged. The percentage of nonviable 
cells was determined by trypan blue staining and used to calculate the 
number of viable cells. The percent inhibition was calculated for the 
different E600 concentrations and the 1DSO determined (35). 
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Dose and Time Dependence: Normal fibroblasts (GM-37, GM-316) and Wolman ~s 
disease fibroblasts (GM-l606) were seeded onto 22 x 22 mm sterile coverslips 
in 35 x 10 mm culture dishes at a density of 5 x 104 cells per dish. The 
cells were treated with varying concentrations of E600 (IO-2M, 3 x lO-3M, 
lO-3M, 3 x IO-4M, lO-4M, IO-SM, IO-6M, none) in HEM plus 8% FCS heat 
inactivated 1 hr at 56°C. The cells were fixed after specified periods 
(0.5, 1, 2, 4, 8, 12 and 16 days) in an aqueous solution of 4% formaldehyde 
and 2% calcium acetate for 1 to 2 hr. The coverslips were stained with oil 
red 0, counterstained with hematoxylin, and scored for the extent of oil 
red 0 positive stain~ng as described in Research Section I (Fig. 1) • 
. Histochemistry: Normal fibroblasts (SaJo, GM-179, GM-37) and Wolman's 
disease fibroblasts (GM-2l09 (P),.GM-l606, GM-2211) were seeded and fixed 
as in the dose and time dependence experiments .d·escribed above. Fixation 
in the Gomori esterase procedure was for 10 min. Untreated cells and 
cells treated with IO-3M E600 for 4 to 9 days were examined. 'The staining 
. techniques employed are shown. in Table 3. Most s.tain reactions were 
carried out in accordance with standard protocols for lipids (49) and 
complex carbohydrates (60). The perm~nganate-aldehyde fuchsin folloWed 
. the method of Landing et a1. (61) and Gomori's «-naphthyl acetate method 
for esterases was performed according to the procedur~ given by Hunt 
(18). Unstained, unfixed cells were examined for autofluorescence on a 
Zeiss Photomicroscope II with an HBO 200 mercury source, a BG3 excitation 
filter, and 41 and 53 barrier filters. Formaldehyde-fixed cells were 
examined by phase contrast microscopy. 
Comparison of Wolman's Disease Cell Cultures: Wolman's disease fibroblasts 
(G~l-2109 (P), GM-1606, GM-2211) were grown on coversl1ps and fixed as des-
cribed in the dose and time dependence experiments above. One coverslip of 
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GM-221l was trypsinized and allowed tore~attacnfor 7 hr be!ore fixation. 
The coverslips were stained wit~ oil red 0, counterstained with hematoxylin, 
and scored for the extent of oil red 0 positive staining as described 
in Research Section I (Fig. 1). 
Lipid Addi tion : Normal (G1:1-498) and Wolman's disease (GM-1606) cells 
were seeded on covers lips in culture dishes as described in the dose 
and time dependence experiment. The cells were treated with varying 
concentrations of cholesterol (Sigma), cholesteryl ester (cholesteryl 
palmitate, Sigma), and free fatty acid (cis-vaccenic acid, Sigma). After 
dissolving 4 .mg of lipid in 0.5 ml of ethanol, which required heating 
for cholesteryl palmitate, the solutions were added to 8 ml of FeS with 
mixi~g and serial dilutions were made. Dulbeccots MEM supplemented with 
8% FCS was prepared with the different lipid-fortified fetal calf sera. 
The cells were treated for 3 days and then fixed, stained, and scored for 
the extent of oil red 0 staining as described in Research Section I-· 
(~ig. _ 1). 
Effect of Serum Concentration and Inactivation: Normal cells (GM-3l6) 
were seeded on coverslips in culture dishes as described in the dose . 
and time dependence experiments above. Replicate cultures were grown 
in media with lO-3M E600 and either fresh FCS or FCS that had been 
heat-inactivated 1 hr at 56°C. The following FCS concentrations were 
employed: 1%, 5%, 15%, and 30%. The cells were fixed after 8 days of 
treatment with calcium-buffered formalin as described in the dose and 
time dependence experiments. The coverslips were stained with oil red 
0) counterstained with hematoxylin. and scored for the extent of oil 
red 0 positive staining as described in Research Section I· (Fig. 1). 
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Comparison of E600 and p-Nitrophenol: Normal.cells (GM-179) .were 
seeded on.coverslips in culture dishes.asdescribed in the dose and 
time dependence experiments above. Cultures wer~ grown in MEM 
supplemented with.15% heat-inactivated (1 hr at 56°C) FCS and varying 
. -4 -4-3 
concentrations of E600 (10 M, 3 x 10 M, 10 M) or p-nitrophenol 
-4 -4 -3 -3 (10 M, 3 x 10 M, 10 M, 3 x 10 M). After 2 days treatment, the 
cells were fixed with calciumrbuffered formalin as described in the 
dose and time dependence experiments. The covers1ips were stained 
with oil red 0, counterstained withhematoxyl1n, and scored for the 
extent. of oil. red 0 s taini:ng as· described in Research Section I (F.ig. 1). 
To estimate toxicity, 5 Chartpak squares, whose approximate area was 
2 2.58 mm each, were placed on each coverslip, the number of cells per 
square were counted and used to calculate the number of cells per 
coverslip. 
Neutral Red Staining: Normal cells (GM-179, GM-37) t Wolman's disease 
cells (GM-1606) , Wolman's disease.heteroz:ygote cells (GM-2l2l, GM-3557 
(M»·, and Bloom's syndrome cells (GM-2548) were seeded on coverslips in 
culture dishes as described in the dose and time dependence experiments. 
Untreated cells and cells treated with lO-4M E600 for 9 days were 
stained 30 min in 0.005% neutral red (filtered before use) and scored 
for the number of positive-staining granules as described for oil red 0 
staine~ granules in Research Section I (~ig. 1). 
Effect on Bacterial Growth: Each of 2 tubes containing 10 m1 of trypticase 
soy broth was inoculated with 0.3 m1 of Escherichia coli cultured WP2 , 
a strain which requires tryptophan. One tube was treated with IO-3M 
E600, the control tube with 0.5% ethanol. The.tubes were incubated with 
aeration for approximately 2 hr. The optical densi.ty was read on a 
:!. 
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Spectronic 20 (Bausch & Lomb) at intervals. When the optical density 
of the control reached 0.42, dilutions of both tubes were prepared in 
Puck's balanced salt solution (PBS). Triplicate pour plates in brain 
-6 -7 -8 heart infusion .agar were prepared at the 10 ,10 ,and 10 dilutions 
-5 -6 -7 -8 of the control, and at the 10 ,10 ,10 ,and 10 dilutions of the 
E600-treated tube. The plates were incubated at 37°C for 2 days and 
counted. 
Results 
Paraoxonase Inactivation: FCS showed ~ignificantparaoxonase activity 
which increased linearly with the concentration of FCS (Fig. 13). Heating 
the 'FCS at 56 ° C reduced paraoxonase activi ty (Fig. 13). There appeared to 
be a significant percentage of paraoxonase activity that was resistant 
to heat~ng at 56°C (Fig. 14). However, heating at 70°C for 10 min 
abolished much of'this activity (~ig. 13). Gamma irradiation had no 
effect on FeS ~paraoxonase activity (Fig. 15). 
Growth Curve: Growth was not inhibited by either lO-5M or lO-4M E600. 
At lO-3M E600 both normal and Wolman's disease cultures showe~ growth 
inhibitioIl (Figs. 16,17). Wolman's disease cells appeared to be somewhat 
more susceptible to E600 than normal cells. The trypan blue viabilities 
were comparable, except on day 12 and 16 of Fig. 16, in which the E600-
treated GM-2l09 (P) cells showed less viability than the untreated cells. 
Relative Toxicity: There was little difference between the normal cells 
and Wolman's disease cells in sensitivity to E600. After 2 days the 
normal cells app~ared to be slightly more susceptible than the Wolman's 
disease cells (Fig. 18). The 1D50 for GM-179 was calculated to be 0.7 
DiM E600 and the IDSO for GM-1606 was 0.95 mM. However, by 6 days the 
situation was reversed, as the Wolman's disease cells exhibited slightly 
more inhibit~on that.the normal.cel1s (R!g. 19) •. The 1DSO for GM-179 
now measured 0.4 ~~ and the ID50 for GM-1606 was 0.24 mK E60Q, 
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Dose. and Time Dependence: A conspicuous increase in lipid sto~age in 
cells exposed to E60D was noted in both normal cultures, GM-37 (Fig. 20) 
and GM-316 (~ig. 21). After seeding, 10 to 24% of the untreated normal 
cells exhibited low levels of lipid storage. This proportion increased 
to as much as 80% with increased time in culture. However) the extent 
of lipid storage never approached the level seen in cells treated with 
lO-4M E60D or untreated Wolman's disease cells. Normal cells treated 
with IO-6M E600 showed an extent of lipid storage similar to that of 
time-matched controls. Altho~gh culture GM-37 appeared to show some 
lipid storage after treatment with IO-5M E600, the GM-316 culture did 
not clearly express lipid storage until treated with IO-4M E600. At this 
concentration very little time-dependent increase in lipid accumulation 
was observed. Normal cells treated with 3 x IO-4M E600 showed a slight 
increase in time-dependent lipid s tor.age, whereas cells treated wi th 
lO-3M E600 showed a pronounced time-dependent build-up of lipid. At 
3 x lO":"3M, some lipid stor.age was observed, but the cells died within 
4 days. All cells were killed by 10-1M E600 within 12 hr. 
Untreated Wolman's disease cells showed a more marked lipid accumulation 
than normal cells with time in culture after seeding (Fig. 22). The 
extent of lipid already present in the cells made it difficult to detect 
-4 -4 inCl"eased lipid stor.age in treatment with 10 M and 3 x 1.0 M E600. 
However, at lO-3M E600, an increase in lipid accumulation was evident. 
-3 When cells that had been treated with 10 M E600 for 12 hr to 4 
days were removed from E600 and grown in normal media, the levels of 
stored lipid dropped, approac~ng those of untreated cells (~igs. 20,21). 
Generally, the l~nger cells had ,been treatedtthe longer it took to reverse 
the lipid sto~age. GM-37 cells treated for 12 hr required more than 
1.5 but less than 3.5 days to return to controls levels. GM-37 cells 
treated 1 day took more than 3 but less than 7 days, whereas cells treated 
for 4 days had not reached control levels 9 days after removal of E600. 
The GM-3l6 culture appeared to reverse lipid storage more rapidly than 
the GM-37 culture. GM-316 cells treated 12 hr returned to control levels 
12 hr later and those treated for 1 day returned to control levels within 
3 days. 
Histochemistry: Refractile granules were observed by phase contrast 
microscopy in the cytoplasm of all fixed, unstained Wolman's disease 
-3 cell cultures as well as in normal cultures treated with 10 M E600 (Fig. 
23). Crystalline inclusions were also visible-in all but the untreated 
controls. Similar inclusions were observed in unfixed cells. 
Like untreated Wolman's disease cel1s, normal cells treated with 
lo-1M E600 showed the presence.of neutral lipid, as evidenced by positive 
staining with oil red 0, sudan black B, and nile blue sulfate (Table 
3). The oil redO positive lipid was pyridine extractable. Both E600-
treated normal cells and untreated WoLman's disease cells gave intense 
staining for cholesterol, both by the perchloric acid naphthoquinone 
and Schultz reactions. The Wolman's disease cells did not stain by Schnabel's 
procedure for differentiating cholesterol and cholesteryl esters by which 
o11ly free cholesterol stains. The E600-treated cells, both normal and 
Wolman's disease, showed a small number of positive granules. This indicates 
that both WoLmants disease and E600-treated cells stored a large amount 
of cholesteryl ester, and that the E600-treated cells also stored a small 
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TABLE" 3 
HISTOCHEMISTRY OF NORMAL AND WD CELLS, UNTREATED AND TRElTED VITH 10-3M £600 
Staining Substance Stain Intensity of Cytoplasmic: Cranules 
technique Sta hed Norllat cells WO cells E600-treated normal cells E600-treated VO cells 
Sudan black B neutral lipid. 
phospholipid 
0 ++++ +t+t 
Lnl1.'s oil red 0 neutral lipid 0 ++++ ++++ ++++ 
Pyridine extraction. non-lipid. 011 red 
ofl red 0 o + material 0 0 0 
Clfn's Nile blue neutral lipid (red) 
sulfite acidic lipid (blue) 0 ++-fA ....... ....... 
lorton's bromine- unsaturated lipid + + + + 
s11ver 
Performic acid- unsaturated lipid 0 0 0 
Schiff 
Copper phthalocyanin phospholipid .b .b,c .. b.d ++btd 
tfolcz1nger I S copper- free fatty acid .' +1 .. ' ++1 rube.nfc acid 
Schultz method cholesterol. cholesteryl 0 +++f +++1 +++f.9 
esters 
Schnabells differen- cholesterol, not 
tiation of Schultz cholesteryl esters 0 0 + • _thad 
"AdIIll'S perchloric cholesterol, cholesteryl 
actd-naphthoqui none esters 0 ••• ++++ ++++ 
Auton uorescence + .+++ ++++ 
Periodic acid-Schi ff glycolipid, glycogen, 
(PAS) mucosubstance + to ++/ + to ++/ • ++/0 to+ +++/0 to + 
(cytoplasmic matrix/ Oto +, +++h o to +~++' 
granules) 
PAS-Diastase same as above same as above same as above saale as above 
'el"llll.nganate-
.1dehyde fuchsin 
probably lipofuscin 0 o,++~ 0 0 
6oIIIor1 's esterase non-specific esterase o to + o to + o to + 
pit 7.4 
_ri's esterase non-specific esterase o to + o to -+ o to + 
pH S.Q 
Aldehyde fuchsin- sulfated (purple), 
.1cian blue carboxyl (blue) 0 0 0 
mucosubstance 
A1cian blue, pH 2.5- neutral (magenta), acidic 
+k + ... i,k .k .k PAS {blue-purple; 
mucosubstance 
Aleian blue. ph 2.5 acidic mucosubstance 0 0 0 0 
Alcian blue. pH 1.0 sulfated mucosubstance 0 0 0 0 
tee1)s stained pink indicating presence of neutral lipid. E600-treated celts showed pink cytoplasmic staining and pink-staining granules. wftere.5 
WOllin's disease cells only showed the latter. 
bNuelei and nucleoli stain. 
CGH-221l showed some small dark staining granules in cytoplasm. 
dOIrker staining in perinuclear location. possibly representing Golgi zone. 
'Nucleoli stain. 
'WOlman'S disease cells showed small to medium-sized. blue-green granules. E600-treated cells showed gray-green granules, some of which were quite 
large. 
'£xOCytosis of lipid granules was visible. 
~37 showed strong staining around large cytoplasmic granules. 
tGM-2211 snowed many small PAS-positive granules. 
jGM-2109 showed small PHAF-posittve granules throughout cytoplasm. 
kcytoplls-ic ~trix stained with PAS as 5bove. nuclei stained with alctan blue. 
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but definite amount of unesterified cholesterol. Untreated Wolman's 
disease cells and E600-treated normal cells were both highly 
autofluorescent (Fig. 24). 
Holczinger's fatty acid stain was weakly positive for nonnal and 
Wolman's disease cells and somewhat more strongly positive for E600-treated 
cells. In both the nile blue sulfate and fatty acid stains, the 
reactivity in the E600-treated cells appeared to include staining that 
was not associated with granules. The copper phthalocyanin procedure 
for phospholipid sta~ed a perinuclear region of E60D-treated cells that 
may have represented the Golgi zone. The GM-2109 (P) Wolman's disease 
culture, but not Wolman's disease culture GM-1606, was positive for the 
perm~nganate-aldehyde fuchsin stain. This stain is thought to be reactive 
to lipofuscin-like material (62). Neither untreated nor E600-treated 
normal cells showed any reactivity to permanganate-aldehyde fuchsin. 
The presence of lipofuscin-like material may be related to the early 
senescence of the GM-2l09 (P) culture. No difference in reactivity was 
observed among controls, Wolman's disease cells, and E600-treated cells 
. . 
for unsaturated lipid, glycolipid, or "mucosubstance. The stain reactivity 
-3 of the Wolman's disease cells treated with 10 M E600 was comparable to 
that of the similarly treated normal cells, although somewhat more 
intense in the former. 
Comparison of Wolman's Disease Cell Cultures: There was considerable 
variation in the amount of oil red 0 positive lipid stored by the 3 
Wolman's disease cultures (Fig. 25). Culture GM-1606 showed little to no 
lipid accumulation when first obtained, but after approximately 3 months 
in culture significant lipid accumulation was observed. Culture GM-22l1 
and GM-2109 (P) both exhibited lipid accumulation from the time they were 
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obtained. Culture GM-2l09 {P} stored the most lipid,; grew the slowest, and 
reached senescence after only approximately 18 population doublings. 
No significant differences were seen in the amount of oil red 0 
positive lipid stored by the GMr2211 Wolman's disease culture before 
and after trypsinization (Fig. 26). 
Lipid Addition: Increased lipid sto~age was seen in normal cells treated 
with 4.0mg% cholesterol, but no lipid storage was seen at lower 
concentrations or in Wolman's disease cells (Fig. 27). Treatment with 
free fatty acid resulted in increased lipid storage in both normal and 
Wolman's disease cells at concentrations of 0.04 mg% and 0.4 mg% (Fig. 27). 
More lipid was stored at the ~igher concentrations. The highest 
concentration, 4.0 mg%,was toxic to the cells. In hoth treatment with 
cholesterol and free fatty acid, the observed lipid storage differed from 
that seen in Welman's disease or E600-treated cells. The lipid droplets 
were l~rger and located more peripherally (Fig. 28). No change in lip~d 
storage was seen after treatment with cholesteryl ester. 
Effect of Serum Concentration and Inactivation: The amount of lipid 
stored in normal cultures treated with 10-3M E600 varied directly with 
the concentration of serum in the medium (Fig. 29). At higher serum 
concentrations, the cell~ grown in heat-inactivated serum appeared to 
store more lipid than those grown in fresh serum. 
COmparison of E600 and p-Nitropheno1: p-Nitropheno1, the major metabolite 
of E600 (35,36), appeared to have little effect on the induction of lipid 
-3 storage (Fig. 30). When the concentration of 10 ~M p-nitrophenol was 
reached, lipid accumulation became noticeable, but at this concentration 
less than half of the cells sterad lipid, whereas 90% of cells treated 
with lO-4M E600 sho~ed lipid accumulation. p-Nitrophenol appeared to be 
slightly more toxic to the cells than E600 (not shewn). 
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TABLE 4 
MEAN COLONIES OF E. COLI PER PLATE, UNTREATED AND TREATED WITH IO-3M 
E600. a 
DILUTION CONTROL E600-TREATED 
10-8 7.7 1.7 
10-7 65.0 23.3 
10-6 537.7 217.0 
Mean 6.52 x 10 8 2.06 x 10 8 
aE• coli stain WP2 treated with 10-~ E600 or 0.5% ethanol for 
controls were grown in trypticase soy broth for approximately 2 hr 
-8 -7 -6 with aeration, and 10 ,10 , and 10 dilutions were pour plated 
in brain heart infusion agar, incubated at 37°C and counted 2 days· 
later. 
~lgure 13. Paraoxonase activ~ty of.fetal calf serum heat-
inactivated for varying amounts of time. (A) 0 hr, 56°Cj 
(B) 0.5 hr, 56°C; (C) 1 hr, 56°C; (D) 2 hr, ·56°Cj (E) 10 min, 70°C. 
Increased heati.ng time "resulted in a decrease in paraoxonase activity. 
Figure 14. Paraoxonase activity of fetal calf.serum heated at 
56°C. S.ignificant activity l*las resistant. to heating at 56°e' indicating 
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~igure 15. Paraoxcnase activity of fetal calf serum exposed to 
gamma irradiation or heating. (A) 0 ~..r'; (B) ,25 kr; (C) 50 kr; 
(D) 100 kr; (E) 200 kr; (F) heated at 56°C for 2 hr; (G) heated at 
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~igure 16. Growth curve of (A) SaJo, normal, and (B) GM-2109 (P), 
Wolmm\'s disease cells, untreated (oEl) and treated with lO~3M E600 




0 , 2 4 8 12 
EXPOSURE TIME, DAYS 
6 
B ~--f 5 ~ 
4 +/ 
~ 3\ 0 -
)( 











o 2 4 8 12 
EXPOSURE TIME, DAYS 
~igure 17. Growth curve of (A) G.M-179, normal, and (B) GM-1606, 
Wolman's disease cells,untreated (OEl) and treated with IO-3M E600 
(ell). E600-treatment was s~ightly more toxic to l-lolman's disease than 
to normal cells. In points without error bars, ,the error bars fell 
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~igure 18. Toxicity of E600 .to (A) GM-179, normal t and (B) 
GM-1606, Wolman's disease cells treated .for 2 days with vary~ng · 
concentrations of E600. E600 appeared to.be s~ightly more toxic 
to normal cells than to Wolman's disease cells. 
Figure 19. Toxicity of E600 to (A) GM-179 , normal, and 
(B) GM-1606, Wolman's disease cells treated for 6 days with 
varying concentrations of E600. E600 appeared to be slightly more 
toxic to Wolman's disease than to normal cells. E600 was more toxic 
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~igul"e 20. Dose and time dependence of E600-induced lipi.d 
,accumulation in GM-37,normal.cells and its reversibility. One hundred 
cells per box were: graded for the extent of oil red 0 positiv~ granulation 
accord~ng to th~ grades shown in Fig. 1 (A) control, exposed to 0.5% 
ethanol; (B) lO-6M E600; (C) lO-.5M E600; (D) lO-4M E600; (E) 3 x lO-4M E600; 
(F)" IO-3M E600; (G) IO-3M E600, 12 hr, untreated thereafter; (H) IO-3M E600, 
24 hr, untreated thereafter, (I) IO-3M E600, 48 hr, untreated thereafter; 
(J) lO-3M E600, 4 days, untreated thereafter. GM-37 cells showed 
time-dependent increases in li.pid . storage which were minimal at lO-4M 
. -3 -3 
E600 and pronounced at 10 M E600. (G-J) cells were trea ted wi th 10 M 
E600 for the specified period, rinsed with Puck's balanced ,salt solution 
and incubated in medium contami:ng 0.5% ethanol until fixation. After 
removal of the E600, the cellular lipid accumulation returned to control 
levels (A). 
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~igure 21. Dose and time dependence of E600-induced lipid 
accumulation in GM-316, normal cells and its reversibility. One hundred 
cells per box wer~ graded for the extent of oil red 0 positive granulation 
accord~ng to the grades shown in ~ig. 1. (A) control, exposed to 
0.5% ethanol; (B) lO-6M E600; (C) lO-5M E600; (D) lO-4M E600; (E) 3 x lO-4M 
E600; (F) IO-3M E600; (G) 3 x IO-3M E600; (H) IO-3M E600, 12 hr, untreated 
thereafter. (I) lO-3M E600 t 48 hr, untreated thereafter. GM-316 
cells showed time-dependent increases in lipid storage which were 
-4 . -4 -3' 
minimal at 10 t1 E600 and more pronounced at 3 x 10 M and 10 M E600. 
-3 Toxicity was observed at 3 x 10 M E60D. (H,I) Cells were treated with 
. -3 . 
10 M E60D for the specified period, rinsed with Puck's balanced salt 
solution and incubated in medium containing 0.5% ethanol until fixation. 
. . 
After removal of the E600, .the cellular lipid acctmlulation returned to 
control levels (A). 
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~igure 22. Dose and time dependence of E600-induced lipid 
accumulation in GM-1606, Wolman's disease cells. One hundred cells. 
per box wer~ graded for the extent of oil red 0 positiv~ granulation 
according to th~ grades shown in ~ig. 1. (A) control, exposed to 
0.5%' ethanol; (B) lO-6M E600j' (C) lO-5M E600; (D) lO-4~f E600; 
(E) 3x lO-4M E600; (F) IO-3M E600; (G) 3 x IO-3M E600. Untreated ~ells 
showed pronounced lipid accumulation with increased t~e in . 
culture. Further increases were seen in cells treated with IO-3M 
-3# 
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Figure 23. Lipid droplets and crystals in the cytoplasm of 
Wolman's disease and E600-treated normal cells. (A) GM-179, normal, 
untreated; (B) GM-1606, Wolman's disease; (C) GM-2211, Wolman's disease; 
(D) GM-2109 (P), Wolman's disease; (E) GM-179, normal, treated with lO-3M 
E600. Cells were fixed in calcium buffered formalin and observed by 
.phase contrast microscopy_ X260. 
~ig~re 24. Autofluorescent lipid in. the cytoplasm of' Wolman t s 
disease and E600-treated normal cells. (A) GM-37, normal, 
-3 . 
untreated; (B) GM-37, normal, 10 M E60D for 7 days (C) GM-2211, 
Wolman's disease, untreated. X200. 
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~igure ,.25. Extent of lipid sto~age in different Wolman's, disease 
cell cultures and a normal control. One.hundred cells per.box were 
graded for the extent of oil red 0 positiv~ granulation accord~ng to the 
grades shown in ~ig. 1. (A) GM-179, normal; (B) GM-1606, Wolman's 
dis~ase, 2 months in culture; (C) GM-1606, Wolman's disease, 3 months 
in culture; (D) ~1-22ll, Wolman's disease, 2 months in culture; (E) GM-2109 
(P), Wolman ' s disease, 8 months in culture. Culture GM-1606 did not 
accumulate more lipid than normal cultures until in culture for 3 months. 
~igure 26. Lipid storage in GM-2211, Wolman t s disease cells 
(A) .before and (B) after trypsinization. One hundred cells per box were 
graded for. the extent of oil red O. posi.tiv~ granulation according to the 
grades shown in Fig. 1. Trypsinization appeared to have little effect 
























~1gure 27. Lipid sto~age in GM-498, normal (A,B,C) and GM-1606, 
Wolman's disease (D,E,F) cells treated with varying concentrations of 
cholesterol (A,D), cis-vaccenic acid (B ,E), and cholesteryl palmitate', 
(C,F). One hundred cells per box were graded for the extent of oil 
red 0 positiv~ granulation according to the: grades shown in Fig. 1. 
Cis-vaccenic acid at 4.0 ,mg% was toxic to the cells. (The O.concentr.tion 
values are the means of th~ grades of'300 cells for each culture.) 
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~igure 28. Lipid storage in GM-498, -normal and GM-1606, Wolman's 
disease cells treated with varying concentrations of cholesterol, free 
fatty acid, and cholesteryl ester. (A) untreated; {B}4.0 ,mg% cholesterol; 
(C) 0.4 ,mg% cis-vaccenic acid; (D) 4.0 mg% cholesteryl palmitate. 
Normal cells treated with cholesterol or free fatty acid and Wolman's 
disease cells treated with free fatty acid exhibited large peripheral 
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F.igur~ 29. Lipid. storage j.n G~I-316, normal. cells trea ted with 
IO-3M E600 in the presence of vary~g concentrations of fetal calf . serum. 
One hundred cells per box wer~ graded for the extent of oil red 0 
positive granulation accord~ng to the grades shown in Fig. 1. (A) fresh 
fetal calf serum; (B) fetal calf serum heat-inactivated 1 hr at 56°C. 
E600-induced lipid accumulation varied directly with the serum concentration, 
~igure 30. Lipid sto~age in cells of normal culture GM-l79 
exposed to identical concentrations of (A) E600 and (B) p-nitrophenol. 
One hundred cells per box wer~ graded for the extent of oil red 0 
positiv~ granulation according to the grades shown in Fig. 1. E600, 
th·~ugh less toxic than p-nitrophenol, produce.d significantly more lipid 
accumulation. Results for the untreated control were from the same 
coverslip. 




















~igure 31. Neutral red stain~ng of various cell cultures, 
-4 untreated and treated with 10 M E60D. One hundred cells per .box 
wer~ graded for the extent of neutral.red granulation according 
to grades corresponding to those shoy."11 for oil redO staining in 
~ig. 1. (A) GM-37, normal; (B) GH-179, normal; (C) GM-2548, Bloom's 
syndrome; (D) GM-3557, mother of proba.nd; (E) GM-1606, Wolman's 
disease. E600-treatment resulted in increased neutral red granulation. 
. 53 






~igure 32. Neutral red stain~ng of various cell cultures, 
untreated and treated with lO-4M E600. (A) GM-37, normal; (B) GM-179, 
nOl~mal; (C) GM-1606 , Wolman's disease. Clear granules are also visible 




F,igure 33. Neutral red stain~ng of a Wolman IS disease 
heterozygote cell culture, GM-2121. (A) One hundred cells were graded 
for the extent of neutral.re~ granulation according to grades 
correspond~ng to those shown for oil red 0 stain~ng in Fig. 1 . 
. (B) Linear arrangement of neutral re~ granules •. X570. The GM-2I21 
cell.culture had more neutral red granules than other untreated cell 




~eutral Red Staining: Wolman's disease cells did not show more neutral 
red granules than normal cells (F.igs. 31,32). E600-treated cells showed 
an increased number of neutral red granules. E600-treated cells, both 
normal and Wolman's disease, also exhibited clear granules that did not 
stain with neutral red (Fig. 32). The GM-2l21 culture showed more neutral 
red granules than the-other untreated cultures, and the granules appeared 
to be arranged linearly (Fig. 33). 
Effect on Bacterial Growth: The number of colonies per plate are shown 
in Table 4. When the results from each concentration were averaged together, 
the untreated E. coli tube was calculated to number 6.52 x 108 organisms per 
m1 whereas the E600-treated tube showed only 2.06 x 108 organisms per mI. 
At the time the tubes were plated, their respective optical densities were 
0.42 and 0.26. 
Discussion 
The shape of the curve for paraoxonase inactivation (Fig. 14) 
s,uggests that FCS contains two enzymes wl.th paraoxonase activity which can 
be separated on the basis of their sensitivity to heating (31,32). The 
paraoxonase activity of Fes can be reduced to less than half by heating 
at 56°C for 1 hr. Because further heating produced only a slight reduction 
of paraoxonase activity but could have had effects on other factors 
necessary to cell growth, FCS was inactivated for 1 hr at 56°C in 
experiments in which cells were treated with E600. Heat inactivation did 
not result in decreased, lipid storage (Fig. 29). In fact, a slight increase 
in lipid storage was seen, presumably due to the maintenance of a higher 
E600 concentration in medium with heat-inactivated serum. 
-5 -4 No evidence for E600 toxicity was seen at 10 M or 10 M E600 in the 
growth curve,· although the relative toxicity experiment showed some inhibition 
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at lO-4M E600. by day 6. .At lO~3M E600 both th~ growth curve and the 
relative toxicity experiment showed some.toxic~ty-to cells. Increased 
time of exposure resulted in ~ncreased toxicity in both experiments. 
Typically the extent of cell toxicity is proportional to the test 
concentration and the duration of incubation (63). Wolman's disease cells 
appeared to be slightly more susceptible to E600-induced killing than 
normal cells (Figs. 16,17,19). Wolman's disease cells, because they are 
deficient in acid lipase, might be expected to rely more on other enzymes 
that are sensitive to E600. However, the lack of any significant toxicity 
-5 -4 at 10 M and 10 M E60D, concentrations that should completely inhibit most 
esterase enzymes (27), makes this hypothesis less likely. It is possible 
that cytoplasmic enzymes are exposed to a lower concentration of 
E600 than the lysosomal enzymes, because lysosomes fuse with phagocytic 
vacuoles which may carry E600 into the cells. Perhaps the lip'id storage 
already present in Wolman's disease cells caused the~ to reach' toxic levels 
of lipid sl.ightly before the E600-treated normal cells. Respiration may be 
affected by organophosphates like E600 (38,64). Because the Wolman's 
disease cells are already under stress due to their enzyme deficiency, they 
may show a decreased ability to resist other stressful stimuli. 
E600 appeared to be quite toxic to bacteria. The tube grown without 
-3 E600 showed 3. 2 times as many viable o,rganisms as the tube with 10 M E600. 
The optical density, which shows the live and dead organisms, showed only 
1.6 times as many cells in the untreated tube. This discrepancy could 
be explained if the E600-treated tube contained 2.06 x 108 viable 
8 organisms and 1.98 x 10 dead o.rganisms. Because the tubes were incubated 
for only 2 hr it is unlikely that the E600 had degraded sufficiently to 
cause an increase in optical density. It is unclear whether the growth 
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inhibition is due to bacterial dependence upon lipase or esterase activity 
for growth or an effect of E600 on bacterial respiration. 
The wide variation seen in the amount of lipid stored by the 3 
Wolman's disease cultures (Fig. 25) may indicate different levels of 
residual acid lipase activity, but it may also reflect the different growth 
rates of the 3 cultures. When the GM-l606 WoL~an's disease culture was 
first obtained, it proliferated rapidly and exhibited little lipid 
accumulation for about 2 months. After 3 months, in cells of a similar 
pas~age level, the growth rate had slowed and lipid accumulation was 
noticeable and has continued to be since. Kyriakides ~ ale (42) also 
obsented a Wolman's disease fibroblast culture that did not store lipid 
until it had been in culture 3 months. The GM-2l09 {P} culture was the 
slowes~ grow~ng Wolman's disease culture and it accumulated the most lipid. 
After only 18 population doublings, the cells exhibited the typical. 
characteristics of a senescent culture including lower growth rate, low 
density, and large cells (Fig. 23), which Kontermann and Bayreuther have 
called type II fibrocytes (65). It is not known whether or not the 
presence of large amounts of stored lipid may shorten the lifespan of a 
fibroblast cell culture. In actively growing cultures there are fewer non-
proliferative cells, and the short generation times and the rapid formation 
of,new cytoplasmic material in the proliferative cells may have the effect 
of diluting the stored lipid. The rapidly proliferating cells have a high 
metabolic activity as well, and may be able to utilize more lipid for energy 
or membrane biosynthesis,. Thus lipid storage may not be 111B.nifested as 
clearly in the rapidly proliferating cells. Regular subcultivation and 
other culture conditions may be important in determining the degree of 
expressivity of this mutation in vitro. 
The lipid stored in cells treated with free fatty acid was probably 
t~iglyceride and phospholipid (66,67). Storage may have increased more in 
the Wolman's disease cells than in the normal cells. The reverse appeared 
to be true in cells treated with choles terol. The Wolman's disease cells 
may require more cholesterol for membrane synthesis because they cannot 
obtain cholesterol from cholesteryl ester. The normal cells, therefore, 
may be experiencing a greater effective concentration of cholesterol 
because they have less use for the cholesterol and are also still 
metabolizing cholesteryl esters. This may result in cytoplasmic 
esterification of the cholesterol. The morphological difference between 
these cells and E600-treated cells may result from tile difference between 
cytoplasmic and lysosomal stor.age of lipid. Cholesteryl ester is normally 
taken up as a component of low density lipoprotein (LDL). The lack of 
lipid 'storage in cells treated with cholesteryl ester was most likely due 
to the form of the lipid. If isolated LDL had been added, the result would 
probably have been quite dif!erent (9). 
Some of the crystals seen in Wolman's disease and E600-treated 
normal cells were most likely cholesteryl ester, but some may also 
represent triglyceride that had been crystallized by formaldehyde fixation 
(68). Cholesteryl ester crystals have also been visualized by electron 
microscopy in cultured Wolman's disease cells (Research Section IV) and 
tissue from Wolman's disease patients (16,69, 70). The autofluorescent 
granules seen in the Wolman's disease and E600-treated normal cells were 
probably lipid. It is not clearly established whether or not neutral 
lipids or free fatty acids are fluorescent (71-73). Various oxidized 
derivatives of neutral lipids are believed to be fluorescent (74-76) 
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and fluorescence is a fundamental cha}:'acteristic.o£ lipofuscin and ceroid. 
Oxygenated steryl.esters (77) and ceroid (78) havebeen.reported to be 
present in tiasues from Wolman's disease patients$ but the reported 
lipids have not been shown to,be autofluorescent. Partin & Schubert (79) 
reported autofluorescent foam cells in an intestinal biopsy from a patient 
with cholesteryl ester storage disease. The autofluorescence we saw in 
Wolman's disease and E60D-treated cells n~y be due to oxidized and 
peroxidized lipids or to the low grade fluorescence from large accumulations 
of cholesteroiL~ fatty acids, and tr.iglyceride (71). 
E60D-treated cells were quite similar to Wolman ':s disease cells 
histochemically. Both showed large amounts of neutral lipid and 
cholesteryl esters. Beth did not differ from controls in staining for 
mucosubstance, glycogen, or unstaturated lipid. However, the E600-treated 
cells showed slight increases in free fatty acid, free cholesterol, and 
perhaps phospholipid which were not observed in Wolman's disease cells. 
The E600-treated cells may resemble Wolman's disease cells because they 
have deficient acid lipase (Research Section III), but if so, they 
probably have reduced activity of other enzymes as we11. 
The lipid stored in E600-treated cells was derived from serum, an 
expected finding for cultured cells (9,66,67,80), and much of it appeared 
to be cholesteryl ester. Goldstein et a1. (9,80) have shown that 
cholesteryl esters are taken up as a component of LDL at a spec~fic 
LDL receptor and are degraded in the lysosomes. The free cholesterol 
generated leaves the lysosome and exerts several regulatory actions, 
including the suppression of the synthesis of LDL receptor molecules 
and the resultant reduction of the amount of LDL taken up. In 
acid lipase deficient cells (Wolman's disease and cholesteryl 
" 
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estersto~age disease), . the cleayage o{.cholesteryl esters is reduced, 
so no free cholesterol is formed.result~ng in no inhibition of LDL 
receptor synthesis. Under these conditions, the cell continues to take 
up large amounts of LDL-cholesteryl esters. The sto~age of cholesteryl 
esters in E600-treated cells may have a similar mechanism. 
-6 -5 
Treating cells with 10 M and 10M E600 appeared to have little 
effect on them, but ,at lO-4M E600 definite lipid accumulation was observed. 
This concentration of E600 had little toxicity. p-Nitrophenol, at the 
-4 same concentration, had no apparent effect. Cells treated with 10 M 
and 3 x lO-4M E600 showed little pr.ogressive build-up of lipid with time, 
s.uggesting that at these concentrations enzyme inhibition and lipid 
storage were balanced by E600 ~egradation, the metabolism of stored lipid, 
and the synthesis of new enzyme. At lO-~M E600 this balance w~y have 
been upset, for a more progressive time-dependent accumulation of lipid 
was observed. Although E600 is somewhat toxic to the cells at this 
concentration, this is probab.ly not related to the lipid storage. 
p-Nitrophenol, at the same concentration, is slightly more toxic, but 
has much less effect on lipid storage •. Although p-nitrophenol has been 
reported to be significantly more toxic than E600 (35,36), if the authors 
had measured the concentration in molarity rather than parts per million, 
the results would have been different. There would have been no difference 
in toxicity to fibroblasts, although p-nitrophenol would still have been 
more toxic to HeLa cells. 
The reversal of lipid accumulation that occurred when E600 was removed 
from the medium was probably due in part to the synthesis of new enzyme 
(37) and in part to the slow return of activity to inhibited enzyme (81). 
The return of activity may be caused bv hydrolysis of the phosphate group 
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transferred t,o a . functional site of -the enzyme by E600 dur~ng iuactivation 
(81). Two ethy~ groups are attached to the transferred phospbat~ group 
in E600-induced enzyme inactivation and the return of activity is, quite 
slow, but with. d;i.methyl p-nitrophenyl phosphate, which has 2 methyl groups 
attached to the phosphate, the rate of hydrolysis is more rapid (81). 
Neutral red granules are believed to be lysosomes (82,83). The 
GM-1606 Wolman's dis-ease culture which was at an early passage level, 
showed the same ntmlber of neutral red granules as the normal cells. 
However, the GM-221l culture, which stored more lipid, appeared to have 
increased neutral re~ granules in an earlier assay. It may be that the 
.age a.nd c011dition of the culture, cell density, FCS c.oncentration and 
variation between FCS lots may be more important in determining the number 
of neutral red granules in a culture than the presence of a lysosomal 
enzyme'deficiency. However, the fact that E600 treatment consistently 
resulted in a significant increase in the number of neutral red granules 
suggests that the presence of, a large amount of stored lipid in the lysosomes 
may s~imulate cells to increase the formation of lysosomes. Typically, 
lysosomal storage diseases show increases by biochemical assay of some 
lysosomal enzymes other than the deficient one (17,84,85). Increased 
neutral red granules may be a morpho~ogical reflection of this, representing 
an attempt by the cells to clear the stored material and, if the material 
interfered with normal degradation, to maintain sufficient operational 
lysosomes. The granules not stained by neutral red tl~t were observed 
in the E600-treated cells are structures that are not at acid pH and 
may represent non-lysosomal lipid sto~age, lysosomal bodies that have 
lost their acid pH, perhaps due to the buffering action of storage products, 
or vacuoles unrelated to lipid storage. The linear arr~ngement of neutral 
re~ granules .apparent ~n the G~~2121.cultuxe.and hinted.at in other 
cultures s.~ggests that lysosomes may be'~rganized by microtilaments, 
microtubules, or other structural components of the cell. 
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RESEARCH SECTION III 
Introduction 
The similarity of the histochemistry of E600-treated cells and 
Wolman's disease cells shown in Research Section II suggests that E60D 
(diethyl p-nitrophenyl phosphate) may be inhibiting acid lipase. E600 
has been shown to inhibit porcine pancreatic lipase by transferring a 
diethylphosphory~ group to a serine group at an essential site of the 
enzyme (33). The micellar concentration of E600 that inhibits pancreatic 
lipase is similar to the concentration that we have shown to induce lipid 
sto~age (86). 
The histochemical results from Research Section II provided a 
preliminary characterization of the lipid stored in E600-treated cells 
and Wolman's disease cells. Although the lipid stored in tissues of 
Wolman's disease patients has been analyzed thoroughly (2,46,69,77,78,87-91), 
analysis of fibroblast cultures has been limited (42). 
Biochemical techniques such as thin layer chromatography and 
gas-liquid chromatography are useful in quantitation and mor~ specifi~ 
characterization of the stored lipid. This section presents the 
biochemistry of E600-,treated and Wolman f s disease cells, incl uding 
attempts to assay the lipase activity present, the effect of E600 
treatment of cells on acid lipase activity, and biochemical 
characterization of the lipids stored. 
Materirus and Methods 
Acid lipase assaz: To determine the lipase activity of normal and 
Wolman's disease fibroblast cultures, cells grown to confluency 
2 2 
in one 75 cnl and one 150 cm flask were pooled and prepared 
as described in Research Section I. Substrate was prepared as 
described in 0.2 M acetate buffer, pH 4.0, but an equal amount 
was prepared in 0.1 M phosphate buffer, pH 7.0 •. The assay was 
performed as described in Research Section I, but the same 
enzyme source was used and 40 ~1 of specified concentrations 
of E600 were added to the assay flasks. In some experiments 
the enzyme was pretreated with the appropriate concentration 
of E600 for 30 min at room temperature. Protein was not determined 
because the same enzyme source was used, and thus all assay flasks 
received equal protein. 
To determine the long term effects of E600 on acid lipase 
activity, 75 cm2 flasks of normal cells were treated with specific 
concentrations of E600 and prepared and assayed as described 
in Research Section I. 
!hin layer Chromatography and.Lipid Analysis: Tnree 150 cm2 
flasks of the following cultures, whose origin is listed in Research 
Section I, were grown to confluency: GM-49B, GM-2520, GM-207S, 
GM-2121, GM-3557, (M), GM-3558 (F), and JoAl. Six flasks of GM-179, GM-37 , 
and G~1606 were grown. 
2 Only two 150 em flasks of GM-22l1, which 
grew slowly, could be obtained. Three flasks were also grown of 
normal mouse and beige mouse fibroblasts, derived from primary 
abdomi.nal skin cultures of 6 week old female normal black 
(C57 BL/65, +/+) and beige (C57 BL/65, bg/bg) mice. The beige 
mouse bears the trait of the Chediak-Higashi syndrane. The cells 
wer~ grown in medium with 8% FCS suppl~mented with 100 units 
of mycostatin per ml. Mycostatin did not appear to affect lipid 
storage. Three flasks of GM-l79, GM-37, GM-1606 were treated 
with lO-3M E600 whereas the other three received 0.5% ethanol. 
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Heat-inactivated serum was used for these flasks. After 9 days of 
treatment, the cells were washed twice in Puck's balanced salt solution 
(PBS), trypsinized, and each culture was pooled in a 50 ml centrifuge 
tube which was placed on ice. The cells were counted on a hemocytometer 
and the cell number' in each sample was computed. The samples were 
centrifuged at 1000-1100 rpm for 10 min on an International Centrifuge, 
Model CM. The supernatant was drawn off and the pellets were frozen 
tmtil extraction. The samples were thawed i.n 5 mlof PBS, sonicated for 
15 sec on ice on a Heat Systems-Ultrasonics microtip sonicator at 50 watts 
and assayed for protein by the method of Bradford (48). A tube containing 
5 m1 of fetal calf serum (FCS) was prepared al~ng with the other samples 
after the protein was determined. 
Lipids were extracted (92) in 10 ml of 1:1 chlorofor~methanol 
(Fisher) and the lower chloroform layer was recovered following 
cent·rifugation. The upper layer was extracted with another 5 ml of 
chloroform and this second extraction was pooled with the first. The 
solvent was evaporated with a stream of air and the lipid resuspended 
in 4.5 m1 of chloroform. 
The total lipid in each sample was assayed by a technique based 
on the ability of lipid to reduce dichromate (93) with pooled 
Paramecium lipid (l.17J.1g/ml) as a standard. One hundred or 200 }.Ill of 
sample was added to an acid-washed tube and solvent was evaporated. 
To each tube, 2 ml of acid dichromate was added (0.75. g of K2Cr207 
was dissolved with heating in 5 ml of deionized water, cooled and made 
up to 500 ml with 98% H2S04). Tubes contain~ng lipids were heated 
to 100°C in an oven or water bath for 20 min. After cool~ng, 
4.5 ml of deionized water was added to each tube with mix~g. 
A blank was prepared by reduc~ng the dichomate with 0.1 mlof 
10% Na2S03 (Baker, anhydrous). The color reaction was read on a 
Gilford spectrophotometer at a wavelength of 440 nm. The results of 
3 assays were ave~aged to deter¢ne the total lipid present in the 
samples. 
Up to 500 pg of lipid was applied to silic~ gel plates which 
had been heated at 120°C for 20 min (Supelcosil 12At Supelco 
Inc., Bellefonte, Pa.), and the neutral lipid classes were separated 
by thin layer chromatography (94) in a solvent system of petroleum 
ether-diethyl ether-acetic acid (80:20:0.5, Fisher). Standards of 
cholesterol (~igma), cis-vaccenic acid (Sigma), tripalmitin (Eastman), 
and cholesteryl palmitate (Sigma) were co-chromatographed to identify 
lipid classes. After development, the plates were air-dried. Some 
were sprayed with 50% sulfuric acid (Fisher) and charred in an oven 
at 100°C for 10 min to visualized the lipid spots. Other plates 
were examined under l~ng wave ultraviolet light and the spots were 
circled and scraped into tubes. Separate dichromate assays were 
conducted for cholesterol, free fatty acid,cholesteryl ester, 
triglyceride nnd phospholipid with cholesterol, cis-vaccenic 
acid and cholesteryl palmitate as standards for the former three 
and cottonseed oil (Fisher) as a standard for the la'tter two 
lipid classes. 'llle relative percentages of E".ach lipid class 
were computed for each sample and the already determined 
values for total lipid were used to calculate the quantity of 
each lipid class as the quantity of lipid per cell and lipid per 
,mg protein. 
Gas-liquid chromatography and phospholipid analysis: Two 150 
2 em flasks of GM-179 and GM-1606 cells were grown to confluency. 
One of each was treated with IO-4M E600 for 8 days. The cells 
were prepared as in the lipid analysis experiment. Briefly, 
cells were washed twice in PBS, trypsinized, pel1eted, and counted. 
They were sonicated and protein was assayed. A sample of 5 ml 
of FeS was also assayed for protein. 
Lipid was extracted from the 5 samples with chloroform-methanol 
(l:l).and two subsequent chloroform extractions. The neutral lipid 
classes were separated on Supelcosil 12A silica gel plates and dried. The 
plates were sprayed with 2',7'-dichlorofluorescein (Eastman) and observed 
by long-wave ultraviolet light. The spots were circled and scraped into 
acid-washed tubes. 
Fatty acid methyl esters were prepared from the free fatty 
acid, t~iglyceride, and cholesteryl ester fractions. Two ml of 
1% methanolic sulfuric acid and 4 drops of petroleum ether were 
added to each tube. The tubes were vortexed lightly and heated at 60°C 
for 18 hr. The methyl esters and other lipids were extracted with 
2 ml of petroleum ether after the addition ofl ml of water. 
The petroleum ether (upper) layer was pipetted into a clean tube. 
The original tube was extracted with another 2 ml of petroleum ether 
and the upper layer was pooled with.the fi~stextract. The solvent 
was evaporated and the samples were dissolved in 50 ~l of petroleum 
ether and spotted on Supelcosil 12A silic~ gel plates. The plates 
were developed in petroleum ether-diethyl ether-acetic acid 
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(80:20:0.5) and dried. After spraying the plates with 2',7'-dichloro-
fluorescein, the m~thyl ester spots were circled and scraped into 
clean tubes. The methyl esters were extracted with 4 ml of chloroform-
methanol (1:1) and one drop of water. The tubes were vortexed, 
centri~uged to br~g down the silic~ gel, and the extract was poured 
into a clean tube. This was repeated twice, pooling the extracts 
from each sample. The solvent was evaporated under a stream of air. 
Fatty acid methyl esters were analyzed by gas chromotography on a 
Hewlett-Packard flame ionization 5711A gas chromatograph fitted with a 
50 meter x 0.5 mm glass wall-coated open-tubular column coated with 
Apolar-5CP (Applied Science Corp.). The conditions were: oven 
temperature l80oC, injector 250°C, detector 300°C, helium pressure 
60 p~ig. Fatty acid methyl ester species were identified by comparison 
with the retention times of appropriate fatty acid methyl ester standards. 
The product of the retention times and peak heights for each sample 
were used to calculate the relative percentage of each fatty acid in 
the sample. 
The phospholipids separated earlier were extracted from the 
silic~ gel with 4 ml of chlorofo~methanol (1:1) ,and one 
drop of water. The tubes were vortexed and centrifuged to bring down the 
silica gel. The extract was poured into a clean tube and the 
procedure was repeated, pooling the two extracts. The samples were 
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dried, redissolved in 50 ~l of chloroform and each· sample was spotted 
on the r.ight-hand corner of a Supelcosil 42A silicB: gel plate. Two 
dimensional thin-layer chromatography was performed in solvent 
systems consisting of chloroform-methanol-water (65:35:4) for the 
first dimension and, in chloroform-acetone-methanol-acetic acid-water 
(5:2:1:1:0.5) for the second dimension. Some plates were sprayed with 
50% sulfuric acid and charred to visualize spots. Other plates 
were developed in iodine (Fisher) to visualize spots. After the 
iodine had faded, they were sprayed with ninhydrin: (0.2% in butanol, 
Pierce) to detect phospholipids with amine groups. The spots were 
circled and scraped into clean tubes. An attempt was made to assay 
the samples for phosphorous (95) us~g ~a2HP04·7H20 (Fisher) as a 
standard. 
Results 
A normal fibroblast culture homogenate showe~ greater lipase 
activity at pH 4 than at pH·7 (Table 5). The activity at both pH's 
exhibited little inhibition at lO-5M E600 but significant inhibition 
at IO-3M E600.' However, at IO-3M E6o"O, the optical density at the first 
point (2 min) dropped from 20 to 6, maki,ng the interpretation of the 
results more difficult. The lipase activi~y of the untreated Wolman's 
disease culture homogenate, though less than normal, was, greater at 
pH 4 than at pH 7 and also exhibited little inhibition at lO-5M E600 
but signi,ficant inhibition at 10-3M E600 at both pH's. Pretreat~g 
the enzyme source with E600 for 30 min did not appear to change 




ACID LIPASE ACTIVITY OF NORMAL AND WOLMAN'S DISEASE CELL HOMOGENATES TREATED WITH VARYING CONCENTRATIONS OF E600.
8 
Cell strain pH E600 concentration (M): 0 10-6 10-
5 10-4 10-3 
4 Activity 
b 2.21 2.12 l.94 1.59 0.01 
GM-37 % 100 96 88 72 0 
(Normal) 
7. Activity 0.97 1.00 0 .. 83 0.66 0.08 
% 100 103 86 68 8 
4 Activity 0.64 0.81 0.63 0.27 0.04 
GM-1606 
% 100 127 98 42 6 
(Wolmants disease) 7 Activity 0.36 0.48 0.56 0.35 0.06 
% 100 133 156 97 17 
GM-37c 4 Activity 1.44 1.91 1.24 0.80 0,0 
(Normal) % 100 133 86 56 0 
aC~nfluentce11 cultures were trypsinized, pelleted, and sonicated on ice with a microtip sonicator, Homogenates were assayed 
for acid lipase by a f1uorometric technique with the appropriate concentration of E600 1n the assay mixture. 
bNanomoles of 4-methylumbelliferyl oleate hydrolyzed perl min per mg protein. 
c Cells were exposed to the specified concentration of E600 for 30 min at 24°C prior to the assay. 
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Whole normal cells treated witn E600 exhibited-reduced acid lipase 
activity (Table 6). The reduction in acid lipase activity paralleled 
increases in the concentration of E60D except at the highest concentration~ 
-3 -4 10 M. Normal cells treated with 3 x 10 M E600 exhibited levels of acid 
lipase activity comparable to those seen in Wolman's disease cells. When 
-3 cells that had been treated with 10 M E600 for 24 hr were removed from 
E600 and grown in normal medium, there was no indication of the return 
of acld lipase activity. 
Separation of the major lipid classes by thin layer chromatography 
(~ig. 34) revealed a large increase in cholesteryl ester in both Wolman's 
disease and E60o-treated cells. An increase in t~iglyceride was also seen. 
The FCS lipid included much cholesteryl ester, but little triglyceride • 
. The proportion of total lipid that was free fatty acid decreased in 
E60o-treated cells. However, because the total lipid per mg protein 
of the E600-treated cells was much more than that of normal cells 
(Table 7), the free fatty acid content of'E600-treated normal cells 
actually showed a significant increase (p<.02) when the chromat.ograpp,ically 
separated lipids were quantitated by dichromate assay and expressed per rug 
protein (Table 8). The E600-treated normal cells also showed significant 
increases (p<.Ol) in cholesteryl ester, triglyceride, free choleste~ol, and 
phospholipid. The untreated Wolman's disease cells showed increased 
cholesteryl ester and a slight in.crease in free tatty acid. The GM-l606 
culture, but not the GM-2211 culture, showed increased triglyceride. The 
E60D-treated Wolman's disease cells showed increases comparable to the 
E600-treated normal cells, except that no further increase in free fatty 
acid was observed. GM-3557 (M), G~3558 (F), the parents of the local 
C"") ,...., 
TABLE 6 
ACID LIPASE ACTIVITY OF HOMOGENATES OF E600-TREATED NORMAL CELLS. a 
Exposure time E600 concentration (M): 0 10-6 10-5 10-4 3 x 10-4 10-3 10-3b 
c 0.71 ·0.33 0.13 0.07 0.07 0.15 0.05 Activity 
% 100 46 18 10 10 21 7 
24 hr. 
11 days Activity 4.06 4.21 0.80 0.51 0.19 1.00 0.72 
% 100 104 20 13 5 25 18 
aCe!l cultures were exposed to the appropriate concentration of E600 for the specified period'and then trypsinized, pe1leted 
and sonicated on ice with a microtip sonicator. Homogenates were assayed for acid lipase by a fluorometric technique. 
b -3 Cells were treated for 24 hr and 10 days respectively with 10 M E600. They were rinsed with PBS and incubated in control 
medium for 24 hr. 

















GM .. 2211 (Wo1,man' s disease carrier) 
GM-2I21 (Wolman's disease) 
GM-3557 (Proband's mother) 
G~3558 (Proband's father) 
G~2520 (Bloom's syndrome) 
JoAI (Hetachrornatic leukodystrophy) -
~2075 (Chediak-Higashi syndrome) c -
Black mouse (Normal) 
Beige mouse (Chediak-Higashi 
syndrome) 






































Total lipid + S.D. 
(~g) -
720 + 98 
1167 ::;: 316 
1081 +" 63 
1813 + 83 
2/~22 +" 309 
1168 +" 134 
1153 + 13 
189 +" 94 
1994 +" 545 
1706 + 346 
2812 + 507 
524 +" 118 
1/~81 + 161 
1120 + 32 
2583 ± 630 
2108 + 255 







































a -3 Confluent cell cultures. some treated with 10 M E600 for 9 days, were trypsin1zed. counted on a hemocytometer, pe11eted, 
and sonicated on ice with a microtip sonicator. After assaying for protein, the lipid was extracted in cl&lorofo~methanol 





MAJOR LIPID CLASSES OF VARIOUS FIBROBLAST CELL CULTURES (~g lipid/mg protein).a 


















































































































lLipid classes were separated by thin layer chromatography and assayed by an acid dichromate tec~~ique. Values were 
calculated from relative percentages utilizing data from Table 7. 
bDiagnosis of cell strains shown in Table 7. 
~y include some sulfatide storage. 
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proband, and GM-2121, a known Wolman's disease heterozygote, appeared to 
have normal amounts of lipid. When the concentrations of each lipid class 
per cell were ca.lculated (Table 9) the results were similar, but the 
differences were not as significant, probably due to the added variable of 
cell size being introduced. The amount of protein per ce11 did not appear 
to change s.ignificantly with E600 treatment (Table 7). The metachromatic 
leukodystrophy culture, JoAl, did not appear to be storing large amounts of 
sulfat:!.de by phase contrast microscopy. Sulfatide probably was not 
separated from phospholipid by the thin layer chromatographic technique 
employed, so that rulY sulfatide stored in the JoAl cells was included in 
the value shown for the phospholipid class (Tables 8,9), which did not appear 
to be unusually high. 
Both Wolman's disease and E600-treated cells showed fatty acid 
patterns similar to that of fetal calf serum, unlike the untreated nonnal 
cells (Table 10). The normal cells showed more stearic acid (18:0) than 
oleic acid (18:lw9) in all three lipid classes analyzed, whereas Wolman's 
disease cells, E600-treated cells~ and fetal calf serum all had more oleate 
than stearate. This was particularly noticeable in the cholesteryl ester 
fraction, where all but the normal cells showed more than three times as 
much oleate as stearate. The cholesteryl esters of normal cells also 
appeared to contain more short chain fatty acids. E600-treated normal and 
E60D-treated Wolman's disease cells appeared to contain more 16:lw7 than 
the untreated cells.-
The phospholipid plates showed good separation. There appeared to 
be increased sphingomyelin and lysophosphati.dyl ethanolamine in the E600-
treated cells. The results from the phospholipid ana1ysis were poor but 
appeared to indicate some increases in sphingomyelin. phospbatidyl 




MAJOR LIPID CLASSES OF VARIOUS FIBROBLAST CELL CULTURES (pg lipid/ce11).8 

















































































































a . Lipid classes were separated by thin layer chromatography and assayed by an acid dichromate technique. Values were 
calculated from relative percentages utilizing data from Table 7. 
b Diagnosis of cell strains shown in Table l. 




DISTRIBUtION OF FATTY ACIDS IN DIFFERENT LIPID CLASSES OF NO&~, WOLMAN'S DISEASE, AND E600-TREATED CELL CULTURES. 
a 
Distribution of fatty acids (%) 
Upid clas8 Sample 
<16;0 16:0 , 16:1w9 16:1w7 18:0 18:1w9 18:1w7 18 :2w6 other 
GM-179 1.9 22.7 1.8 2.3 29.7 27.2 7.0 4.2 3.3 
GM-179 +E600 3.9 19.9 3.2 6.0 22.5 32.7 11.8 
Free fatty GM-1606 2.0 19.4 3.9 2.4 21.4 34.5 11.1 1.9 3.4 
acid GM-1606 + E600 0.8 18.1 3.5 7.7 16.8 34.7 11.6 6.8 
Fetal calf serum 1.6 27.1 2.5 2:1 21.7 28.6 9.8 6.6 
GM-179 6.4 30.6 5.9 26.7 23.2 10.6 
GM-179 + E600 1.9 21.6 3.8 5.6 13.5 38.4 15.2 
Triglyceride GM-1606 24.8 22.9 34.6 17.7 
GM-1606 + E600 1.1 22.8 3.8 8.6 11.7 37.0 15.2 
Fetal calf serum 9.6 50.0 40.5 
GM-l79 7.2. 32.7 4.9 7.6 23.5 19.3 4.7 
GM-179 + E600 22.7 2.8 4.0 9.7 32.9 9.S 13.3 5.2 
Choleatery1 GM-1606 1.8 26.6 2.4 5.9 7.1 35.1 8.6 5.7 7.2 
ester GM-1606 + E600 2.1 27.2 2.7 7.6 7.2 31.1 9.6 5.7 6.7 
Fetal calf serum 2.6 32.6 2.6 5.3 7.2 23.0 9.4 9.4 7.9 
a Confluent cell cultures were trypsinized, pe11eted, and sonicated on ice with a micro tip sonicator. Lipid was extracted 
with chlorofo~methano1 (1:1) and the major lipid classes were separated by thin layer chromatography. Fatty acid methyl estexe 
were prepared and purified by thin layer chromatography. The retention times and peak heights were recorded on a gas 
chromatograph and used to calculate the relative percentages. 
~igure 34~ Separation of major lipid.classes of various cell cultures 
by thin layer chromatography. (A) Free choles terol control; (B) T~iglyceride 
control; (C) Black mouse, normal; (D) B~ige mouse, Chediak-~igashi 
syndrome; (E) GM-2075, Chedlak-Higashi syndrome; (F) Fetal calf serum; 
(G) GM-179, nonnal, treated with lO-3M E600; (H) GM-37, normal, untreated; 
. -3· (I) GM-37, normal, treated with 10 M E600; (J) Cholesteryl. ester 
control; (K) Free fatty acid control; (L) GM-498, normal; (M) GM-l606, 
Wolman's disease, untreated; (N) GM-1606, Wolman's disease, treated with 
lO-3M E600; (0) GM-3558, father of proband;' (P) GM-3557, mother of 
proband; (Q) GM-2121, Wolman's disease heterozygote; (R) JoAl, 
metachromatic leukodystrophy. E600 treatment lasted 9 days. Lipid was 
extracted from pelleted cells an.d separated on silic~ gel plates. The 
plates were dried, sprayed with sulfuric acid, and.heated to visualize 
the lipids. From 350 to 500 .~g of lipid were used for each culture, so 
plates show .relat~ve·percentages of each lipid class. T~iglyceride . 
. control did not char after sulfuric acid spray and heating because it 
cOlltained only saturated fatty acids. PL-phospholipid; C-cholesterol; 
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Discussion 
Fibroblasts differ from liver cells in having more lipase 
activity at acid pH than at neutral pH (9,14,96). The observed 
lipase activity was resistant to lO-SM E600, indicating that 
it probably represented aci.d lipase at both pH's (16,17). Acid 
lipase usually shows a more narrow pH range for activity (9,14). 
The wide range seen may be due to the buffer system or substrate, 
or it may reflect the relatively low activity of the material 
examined and the consequent decreased accuracy of the assay. 
The conclusion that even the lipase activity at pH 7 was due 
to acid lipase is supported by the find~ngs of other investigators 
that nearly all the lipase activity of fibroblasts is due to 
acid lipase (9,14). 
E600-induced inhibition of acid lipase was generally consistent 
with the histochemical dose and time dependence studies in Research 
Section II (Figs. 20-22). Although 10-6M E600 had no detectable 
effect on lipid storage or acid lipase activity, at lO-5M E600 
there was an 80% inhibition of acid lipase \vith little to no 
effect on lipid storage. Brovm et al. (10) showed that as little 
as 10% of normal acid lipase activity may be sufficient for normal 
function in fibroblast cultures. An 88% inhibition of acid lipase 
and definite lipid accumulation were seen in cells treated with 
lO-4M E600. Treating cells with 3 x lO-4M E60D caused a 95% 
inhibition of acid lipase with slightly more lipid accumulation 
-4 -3 than at 10 M. Although 10 -M E600 induced a more progressive 
time-dependent accumulation of lipid, acid lipase activity did 
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not appear to be maximally inhibited at IO-3M E600. In two assays, 
acid lipase activity decreased as a function of E600 concentration 
-4 -3-4 until 3 x 10 M, but showed less inhibition at 10 M than 3 x 10 M. 
-3 Cell cultures treated with 10 M E600 for 3 hr, 1 day, and 9 days 
each e~libited approximately 75-80% inhibition of acid lipase 
activity_ It is not clear why this occurs. Although E600 did not 
totally inhibit acid lipase, assays for acid lipase in which 
esters of 4-methylumbelliferone are utilized, generally show appreciable 
residual activity even in acid lipase deficient cultures (7). 
The analysis of lipid in Wolman's disease and E600-treated cells 
supported the histochemical find~ngs in showing increased stor,age of 
cholesteryl esters in the cells. The results also showed increased 
tt::ig1yceri.de, which cannot be specifically ,demonstrated histochemically. 
S~ight increases in free fatty acid and cholesterol in E600-treated cells 
were observed both histochemically and by lipid analysis. The latter 
findi,ng was unexpected, because the deficiency or inhibition of an 
enzyme in a metabolic pathway usually leads to a decreased level of the 
products of the inhibited reaction. Degradation of the stored lipid by 
normal or artifactual processes may account for this finding. Free fatty 
acid has been reported to be increased in histological (89,97) and 
biochemical (46,97) studies of tissues from Wolman's disease patients. 
Increased free fatty acid was also· seen in biochemical analysis of the 
liver of the donor of Wolman's disease culture GM-2109 (P) 
~ 
(Dr. H. Jons.son, personal communication). The increase in 
phospholipid found in E600-treated cells was not observed histochemically, 
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altho.ugh there was increased phosllhollpid .staini,ng in a .peX'inucl~ar 
regi,on of the cells which;t it was th~ugh.t, ~ght represent. the G~lgi 
~egion. Numerous amphiphilic compounds have.been shown to induce 
phospholipidos is (98-100). However J E600 lacks the posit! vely ch.arged, 
nitrogen containing, hydrophilic side chain common to these compounds. . . 
The analysis of the phospholipid classes gave no definite result, but it 
appeared that sphingomyelin, phosphatidyl ethanolamine, lysophosphatidyl 
ethanolamine and phosphatidyl choline might all be elevated. No 
significant increase in any lipid class was seen in known or suspected 
Wolman's disease heterozygotes. This supports the histochemical findings 
shown in Fig. 12. Although cells from one carrier were reported to 
store lipid (42), most carriers probably do not. 
The observed lipid accumulation in cells treated with E600 
appears to result, at least in part, from the specific inhibition 
of acid lipase, explaining the similarities of E600-treated cells 
to Wolman's disease cells. Although acid lipase is fairly 
resistant to E60D (13,16,17,101), fibroblasts appear to have little 
other lipase activity (9,14) so that no cellular effeet may be 
manifested until acid lipase is inhibited. However~ ~he storage 
of additional triglycerides and cho1esteryl esters ·tm Wolman's 
disease cells treated with lO-4M E600 indicates eit~ the 
inhibition of residual acid lipase activity or the ~ibition of 
additional enzymes involved in lipid metabolism. Oa1rtner e tal. 
(8) were able to separate, by cel~ogel electrophonesis, 
three isozymes with the ability to cleave 4-MUO under acid 
conditions, only one of which was deficient in Wolman's disease. 
It is possible that E60D is also blocking the other isozymes 
which may have different substrate specificities (8). The 
increased levels of phospholipids in E600-treated cells suggest 
that one or more enzymes jnvolved in phospholipid degradation 
may be inhibited by E600 treatment as well. 
The gas chromatography results support the conclusion 
that the cholesteryl ester stored in Wolman's disease and E600-
treated cells is derived from the cholesteryl ester component 
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of low density lipoprotein in the serum and has not been metabolized 
in the cell. However, normal cells degrade the lipid and, 
When the cholesterol is transported from the lysosome to the 
cytosol, it is re-esterified. The normal cells showed a differenx 
pattern of fatty acids in the cholesteryl ester fraction, suggesting 
that more stearic acid (18:0) is available for re-esterifation 
than oleic acid (18:1009) or that the cholesteryl ester synthetase 
preferentially esterifies the saturated fatty acid. There 
was little triglyceride present in fetal ca1f serum. The triglyceride 
present in the cells was probably derived from the serum free 
fatty acid (66,67). The E600-treated cells may have preferred 
oleic acid (18:1009) to stearic acid (18:0) in the synthesis 
of triglyceride. The gas chromatography of cultured Wolman's 
disease fibroblasts gave results similar to those of other 
analyzed Wolman's disease tissues (46,77,78,91) except for 
an increase in -stearic acid in the triglyceride fraction. 
RESEARCH SECTION IV 
The ultrastructural appearance of the sto~age products 
of lysosomal sto~age diseases is characteristic of the disease 
and in some cases can be used for d1.agnosis (102). Although 
fibroblast cultures do show morpho~ogy typical for a specific 
disease (102,103) J Ornoy' et a1. (103) have s,uggested that amniotic 
fluid cells are more reliable for diagnostic purposes. In Wolman's 
disease, the ultrastructure of liver (16,69,104), adrenal (69), 
lymph node (46), duodenum (104), lymphocytes (101), and for the 
peripheral and central nervous system (70) have been reported. 
Numerous lipid droplets and clefts are structures typically 
observed. Some inves~igators have reported that lipid can be 
either membrane-limited or free in the cytoplasm (69,70) whereas 
others have reported that the lipid is membrane-bound (3,16,101). 
The lipid has been observed in lysosomes, associated with acid 
phosphatase activity (3,16,69). In cholesteryl ester storage 
disease, Partin and Schubert not only demonstrated lipid droplets 
and cholesteryl ester clefts in a detailed study ofsma11 
intestinal biopsies (79), but they also demonstrate4 the presence 
of membrane-bound crystals in fibroblasts cultured from the 
patient (105). Dr.ug-induced lipidoses resemble, ultrastructurally, 
inherited lipid stor,l:lge diseases (98,100) particularly those 
involving a similar sto~age product. 
This section presents ultrastructural and cytochemical 
studies on Wolman's disease and E60o-treated fibroblasts and 
attempts to c.orrelate the information with the histochemical and 
biochemical data. 
Materials and Methods 
Normal (GM-179) and Wolman's disease (GM-1606) cells were seeded in 
35 x 10 mm culture dishes at a concentration of 5 x 104 cells per 
-4 dish. Half the normal cells were treated 11 days with 10 M 
E600 (diethyl p-nitrophenyl phosphate) and embedded in situ by the 
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method of Douglas et al. (106). The cells were rinsed 3 times in Puck's 
balanced salt solution (PBS) (0.9% NaCI for acid phosphatase cells) and 
fixed 30 min in 2.5~ glutaraldehyde (EMS, Fort Washington, Pa.) in 0.1 M 
sodium cacodylate (Fisher) buffer. The cells were rinsed in 0.2 M 
cacodylate buffer and post-fixed 30 min in 1% osmium tetroxide 
(EMS) in 0.1 M cacodylate buffer. After dehydration in graded alcohols, 
the cells were infiltrated in Epon-ethanol (1:1) and then 4 changes 
of Epon (EMS). The next morning, after 2 additional changes of 
Epon, the culture dishes were polymerized at 55°C for 12 hr. The 
polymerized cells were removed from the culture dish with pliers 
and cured for 30 hr at 60°C. The dishes were staineiwith toluidine 
blue and suitable areas were marked. These sections were cut out 
with a coping saw and placed in a Beem Capsule in whi£h they were 
flat-embedded with Epon. Thin sections were examinei on an AEI 
(E~68) or Hitachi (HS-8F-l) electron microscope. The· GM-1606 
monolayers partially detached during glutaralydehydefixation, 
so less cells were available for examination. 
~rEholor~: After thin sections were cut and placed o~ grids, 
the sections were stained in saturated uranyl acetate (Fisher) 
in 50% ethanol, rinsed in distilled water and stained in lead 
citrate (from lead nitrate, Fisher, and sodium citrate, EMS). 
Colloidal Gold: Approximately 55 ml of colloida~ gold (Harleco) 
waS boiled down to 6 ml with stirring. This was di1ute.d in 
medium (1:2) and used to treat the cells for either 2 or 24 
hr before fixation. 
Acid Phosphatase: After glutaraldehyde fixation, staining 
solution was prepared by dissolving 63 mg of a-glycerophosphate . . 
(Sigma) in 5 ml of 0.2 M Tris maleate buffer, pH 5.0 (Sigma) 
and 10 ml of distilled water. The pH was readjusted to 5.0 
with. hydrochloric acid. To this solution was added 10 ml of 
0.2% lead nitrate, drop by drop with stirring. Control solution 
was prepared similarly, but lacked B-glycerophosphate. The 
cells were treated for 1 hr at 37°C. 
Peroxidase: After glutaraldehyde fixation, staining sol~tion 
was prepared by dissolving 3 mg of 3,3'-diaminobenzidine tetrahydro-
chloride (DAB, Sigma) in 10 ml of 0.05 M Tris buffer pH 7.2-
7.6 (Fisher) and approximately 0.02 m1 of 3% hydrogen peroxide 
(Parke-navis). Control solution was prepared without DAB. 
The cells were treated for I hr at room temperature. 
Scanning Electron ~croscopy: Normal cells (GM-37) and Wolman's 
disease cells (GM-1606) were seeded on coversl1ps in culture 
dishes as described in Research Section I. One dish of each 
was treated 8 days witn 10·~ E600. The cells were fixed 
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30 min in 2.5%. glutaraldehyde in 0.2 M cacodylate buffer, 
rinsed in buffer t post-fixed one hr in 1% osmium tetroxide 
in 0.1 M cacodylate buffer, and dehydrated in graded alcohols. 
Critical point dry~ng was performed in a Technics CPA-II critical 
point dry~ng apparatus and, after attaching pieces of coverslip 
with cells to specimen mounts with silver paint (Dotite 
Electroconductives), the samples were coated wit~ gold for 2.5 
min on a Hummer II vacuum evaporator (Technics). Cells were 
examined on a Jeol JSM-25 scanning electron microscope and 
Polaroid pictures were taken.· 
Results 
Transmission electron microscopy (TEM): Normal fibroblast cells 
fixed in situ and examined by TEM revealed features typical of 
an active cell (F.igs. 35,36). Abundant rough endoplasmic 
reticulum and long thin mitochondria were present. Round dense 
bodies probably representing lysosomes were seen scattered throughout 
the cytoplasm and osmiophilic cytoplasmic lipid droplets were 
occasionally encountered. Large clear vacuoles were also observed. Thin 
filaments which were probably microtubules and microfilaments, were 
numerous. The nucleus usually appeared rounded and two or more nucleoli 
were visible. The ce.l1s appeared to have minimal acid phosphatase 
or peroxidase activity. After 2 hr little colloidal gold had entered 
the cells, although some was visible at the cell surface. After 24 hr 
however, more colloidal gold had entered the cells and could. generally 
( . 
be seen in dense bodies, large clear vacuoles, or occasionally 
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in small endocytic vacuoles of intermediate density (Figs. 37,38). 
Wolman's disease fibroblasts showed morphology similar to 
normal cells though some dilation of rough endoplasmic reticulum was 
observed. Crystalloid clefts probably representing cholesteryl ester. 
were visible within dense bodies that were often deformed by the shape 
of the crystals (~igs. 39-41). Large clear vacuoles were numerous and 
appeared more ~ngular than in normal cells. Again no significant reaction 
was seen for acid phosphatase or peroxidase and little colloidal gold 
had entered the cell after 2 hr. After 24 hr the colloidal gold appeared 
to have had some ~egative effects upon the cells. The mitochondria were 
swollen and had areas of clearing. Colloidal gold was usually seen in 
dense bodies, some of which contained lipid clefts, or in the large 
clear va cuoles (~igs. 42,43).' 
. Normal cells treated with lO-4M E600 exhibited numerous lipid 
clefts. Thev generally appeared to be present in dense bodies which, 
til, 
as in the Wolman's disease cells, often were deformed by the shape of 
the crystalloid material (Figs. 44-46). The cells showed increased numbers 
of dense bodies (Fig. 44). Large clear vacuoles were numerous. An 
increase was also observed in multilamellar structures (Fig. 45), similar 
to the lamellar bodies typically seen in drug-in~uced phospholipidosis 
(98). Cells treated with colloida~ gold for 24 hr exhibited colloidal 
gold particles in endocytic vesicles and dense bodies, some of which 
contained lipid clefts (Figs. 47,48). Colloidal gold particles were 
also seen in the l~rge clear vacuoles. Aside from an increase in 
the number of dense bodies, the E600-treated cells resembled 
Wolman's disease cells. Osmiophilic cytoplasmic lipid drop Ie ts 
F,igure 35, Ultrastructure of a GM-179, normal fibroblast fixed 
in situ. Abundant-r~ugh endoplasmic reticulum is visible. Mitochondria 
are l~ng and thia. The few dense bodies are c.lustered near ,the nucleus 
or,scattered,thr~ughout the cytoplasm. N~nucletls;Nu-nucleolus; 
DB-dense body; ER-rough endoplasmic reticulum; M-mitochondrion. 
Stained wi.th uranyl acetate and lead citrate. X5500. 
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~1gure 36. A GM-179,normal fibroblast viewed at a ~igher 
power. Microtubules and.numerous microfilaments are present in the 
cytoplasm. Dense bodies and less d.euse vacuoles are also present. 
N-nucleus; DB-dense body; ER-r~ugh endoplasmic.reticulum; 
Mrmitochondri.on; Xfb-microfilament bundle. Stained with uranyl 
acetate and lead citrate. X15,800. 
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~igure 37. Colloida~ ,gold particles within dense bodies of a 
GMr179 , normal fibroblast. One colloidal gold particle appears 
to be within a small endocytic vesicle (arrow). L-probable cytoplasmic 
lipid droplet. Treated with colloidal gold for 24 hr. Xl7,OOO. 
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gold particles in a GM .... l79, normal 
e in dense bodies and large clear vacuoles 
cytoplasmic lipid oplet. Treated with 
hr. Xl6,800. 
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.~igure 39. Ultrastructure of a GM-1606, Wolman's disease fibroblast 
fixed in situ. The cytoplasm contains many l~ng crystalloid clefts which 
probably represent cholesteryl ester dissolved during processing. 
Thoe crystalloid was often present in dense structures resembling lysosomes. 
Few normal dense bodies are seen. Large.clear vacuoles are present, 
.but appear more B:ngular than in normal cells (arrow.s). N-nucleus, ER-rough 
endoplasmic reticulum; M-mitochondrion. Stained with uranyl acetate and 
lead citrate. X5600. 
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~igure 40. A GM-l606, Wolman's d~sease fibroblast viewed at 
a ~igher power. Numerous clefts are visible within dense bodies,which 
are often deformed by the crystalloid (small arrows). Membrane is 
visible surround~ng some crysta.lloid-containing structures' (la.rge 
arrows). The r~ugh endoplasmic reticulum is dilated. N-nucleus; 
Nu-nucleolus; ER-r~ugh endoplasmic reticulum. Stained with uranyl 
acetate and lead citrate. Xl5,500. 
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~igure 41. Unusual structures in a GM-l606, Wolman's disease 
fibroblast. In addition to the more typical crystalloid-contain~ng 
dense bodies (small arrow), some cells.contained l~rge multivesicular 
bodies. Some of the multivesicular bod~es also appeared to contain 
crystalloid (l~rge arrows). Stained with uranyl acetate and lead 
citrate. X32,300. 
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~igure 42. Colloida~.gold particles in GM-1606, Wolman's 
disease fibroblasts .show~ng local;Lzation to ,dense bodies and la,rge 
clear vacuoles (large arrows). Some crystalloid-contain~ng structures 
also accumulate colloidal: gold particles (small arrows). Cytoplasmic 
lipid droplets did not appear to.be associated with colloida~ gold 
particles. Treated with.colloidal.gold for 24 hr. X15,OOO. Inset 
X32,OOO. 
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F,igure 43. A GM-1606, Wolman t_s disease fibroblast exhibiti.ns 
colloida~ gold accumulation within dense.bodies and l~rgeclear 
vacuoles (arrows) .which appear ~ngular and may contain crystalloid 
material. Col1oida~ gold particles are.also-seen atthe.cellsu~face, 
.but a~e not associated with cytoplasmic lipid droplets •. Treated 
.~th colloida~ gold £o~ 24 hr.X14,700. 
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~igure 44. Ultrastructure of a GM-179,.normal fibroblast 
treated with lO-4M E600 for 11' days and fixed in situ •. The cytoplasm 
is nearly filled with 18:rge clear vacuoles·ap.d.dense bodies which 
.often contain semilunar or angular electron.lucent areas.that 
probably represent cholesteryl ester disso1ved.dur~ng process~ng. A 
small.perinuclear zone lacking dense bodies is visible (arrow) which 
. contains mitochondria, r~ugh endoplasmic reticulum, and microfilament 
.bundles. N-nucleus; M-mitochondrion •. Stained with uranyl acetate 






~igure 45. An E60Q-treated, normal (GM-179) fibroblast viewed at 
a higher power. Numerous dense bodies contain ~ngular and.semilunar 
clefts, some of which. deform t~e shape of the dense bodies (small arrows). 
Some bodies appear to contain concentrically arra.ngedmembranous 
materials (lB:rge arrows). N-·nucleus; ER-rotigh endoplasmic reticulum; 
M-mitochondrion; V-l8:rge clear vacuole; Mfb-microfilament bundle • 
. Stained with uranyl acetate and lead citrate. -X16 ,500. 
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· ~igure 46. A. Dense bodies, clear vacuoles, and cytoplasmic 
lipid droplets fill~ng the cytoplasm of an-E600-treated, QI-179, normal 
fibroblast. Angular and semilunar-clefts are visible within dense 
bodies. L-probable cytoplasmic lipid droplet. X17,500. B. Dense 
body appears -to-befus~ng with a lipid cleft which is already within 
a dense matrix. X15,500. 
100 
Figure 47. Colloida~ gold particles in dense bodies and la,rge 
clear ,vacuoles (l~rge arrows) of an E60Q-treated, GM-179, normal fibro-
blast. Some crystal1oid-contain~ng structures accumulate colloida~ gold 
particles (small arrows) 41 Treated with colloidal gold. for 24 hr .X16 ,600. 
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~igure 48. Accumulation of colloida~ gold particles in.dense 
bodies of an E60D-treated, G~I-179, normal fj.broblast. Colloida~ gold is 
some.times associated wi.th crystal1oid~contain~ng structures. One 
.colloidal gold particle is associated'witn a cytoplasmic lipid droplet 
.(l~rge arrow), but this droplet may.be fus~ng with a secondary lysosome 
next to.it which.contains colloid~ gold •. Treated withcolloida~ gold 
for ·24 hr.· .X15,500. 
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~igure 49. Normal, GM-37. (A,e) and Wolman 1 s disease, GM;-1606 . 
. ·-4 
.(B,D) fibroblasts, untreated (A,B) and treated with 10 M E60Q ... (C,D) 
yiewed by.scann~ng electron microscop¥.Cells show.nuclei, nucleoli, 
and ndcrofilaments . runn~ng l~ngthwise thro.ugh the cells. . The 
E600-treated cells .show.bumps.thr~ughout the cytoplasm except for a 
. perinuclear clear zone (arrows). Tile humps appear to form r~dges 
.al~ng microfilaments. X1400,45° ~gle. 
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~igure 50. Possiblemechanisms.to explain.the presence of 
crystalloid material within. secondary lys.osomes. A. A . lysosome fuses 
with a lipid cleft ly~ng free in the cytoplasm. The.lysosome engulfs 
the.c!eft,whichthereby.alters.its shape •. Eventually another 
lysosome may .fuse with this structure. B. A lipid cleft ~egins . forming 
within the lysosome .which is unable to ~egrade .it. As more lipid is 
taken up, the cleft.expands, stretc~ng.the lysosome. As in A, 
eventually another lysosome may.fuse with this structure. 
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did not appear to be increased in e~tne~.Wolman'a disease or 
E60o-treated cells and did.no~,generally contain colloida~.gold 
particles •. The amount of colloida~ gold uptake varied from cell 
to cell but was not appreciably different in either quantity or 
location in the normal~ E60o-treated, or Wo1man's disease cells. 
Scanning electron microscopy (SEM): Normal cells were indistinguish-
able from Wolman's disease cells by SEM (Fig. 49 A,B). The nucLei 
appeared as smooth ovoid areas with 2 to 4 raised nucleoli. Thin 
strands could be observed running parallel to the l~ngitudinal axis 
of the cell. Aside from these filaments, the cytoplasm appeared 
smooth. Pits were present in the cytoplasm and may have reflected 
the presence of vacuoles covered by fragile areas of cytoplasm,or they 
may have represented artifacts of critical point drying. 
-4 Nonnal cells and Wolman's disease cells treated with 10 M 
E600 showed a distinct change in morpho~ogy (Fig. 49 C,D). The 
cytoplasm became bumpy and the bumps sometimes appeared to be 
linear, running alc,ng the filaments. A perinuclear zone was 
observed which showed no bumps. This was comparable to a clear 
perinuclear area seen by neutral red (Fig. 32) and oil red 0 
stain~ng. The b.umps thus appeared to represent the lysosomal 
lipid storage granules. 
Discussion 
Altho,ugh lipid clefts have been noted in both ~ight and 
electron microscopic studies of Wolman's disease, only Lake and 
Patrick (16) reported that the crystals were membrane-limited, but 
they showed no illustrations. Partin and Schubert (105) reported 
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that fibroblasts from a patient with cholesteryl ester stor,age disease 
contained "semilunar or B:ngular,electron,lucent i~ges innnersed in an 
electron dense material contained Ul membrane bounded structures ' 
probably lysosomes." This is similar to what we observed in Wolman's 
disease and E600-treated cells. The.deformation of . the structures by 
crystalloid material has not been previously noted. The presence of 
the clefts and the concomitant alteration in morphology did not 
appear to interfere with the activity of the structures in fusing 
with endocytic vesicles containing colloidal gold. 
Acid hydrolases are manufactured in the cellon the ribosomes 
106 
of the rough endoplasmic reticulum and are transported via the endoplasmic 
reticulum to the Golgi. In the Golgi the hydrolases are packag~d and, 
when they bud off the Golgi membrane, they are known as primary 
lysosomes. After pinocytotic vesicles and p~agocytic vacuoles are 
formed at the cell surface, they are transported through the cytoplasm 
and fuse· with a primary lysosome which thereafter is called a 
secondary lysosome (phagolysosome). The secondary lysosome digests 
the endocytosed material and continues to fuse with new endocytic 
vesicles. Eventually the lysosome accumulates indigestible material 
and becomes less active. It is now called a residual body. Colloidal 
gold particles are la.rge and inert and they cannot pass through 
the pIa.sma membrane, .but they are taken up by endocytosis. When the 
colloidal gold-carrying endocytic vesicle fuses with a 1ysosome, 
the colloidal gold remains in the secondary lysosome for it cannot 
be digested. Thus secondary lysosomes accumulate colloidal gold (107). 
The crystalloid-containing dense bodies, which were generally larger and 
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denser thanendocytic vacuoles, contained col1oida~ gold and were thus 
considered to be secondary lysosomes. Because Wolman's disease and 
E60o-treated cells stored vastly more cholesteryl ester than normal 
cells (Research Section III), it is likely that the crystalloid clefts 
consisted mainly of chdlesteryl ester. 
Two mechanisms can 'be hypothesized to result in the presence of 
crystalloid within secondary lysosomes. If cholesteryl ester clefts 
were found free in the cytoplasm, perhaps in a struc,ture like the 
clear vacuole, one or more lysosomes might fuse with the crystalloid 
and engulf it (Fig. 50A). Such a mechanism is s~ggested by Fig. 46. 
The accepted mechanism of cholesteryl ester uptake'ri.a the 1m., density 
lipoprotein pathway s~ggests that the clefts may fo~, in the 
lysosomes due to the ,~ggregation of sto~age material (Fig. 50B). 
The 18:rge clear vacuoles were seen in all cell t:ypes, but appeared 
to be more numerous and to be more angular in Wolmam~s disease and 
E600-treated cells. The angularity may have been ~, to the presence 
of cholesteryl ester crystals. The vacuoles may repttesent non-osmiophilic 
lipid droplets, which Partin and Schubert noted in <~rophages in 
cholesteryl ester sto~age disease (79) or macropinocJttotic vesicles (108). 
The vacuoles were often seen in association with lysmomes and sometimes 
the lysosomal membrane appeared to extend around the ~cuole as if the 
lysosome were attempting to engulf the clear vacuole. The presence of 
, . 
colloidal gold in some of the clear vacuoles t. generaIn:y at the periphery 
of the vacuole, suggests that some of these vacuoles ~d fuse with 
lysosomes. Alternately, the clear vacuole may form wnthin a lysosome 
and cause expansion. Other lysosomes may then fuse with it. These 
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hypotheses are analogous to those discussed for cholesteryl ester 
crystals and depicted in Fig. 50. 
No morphological evidence of damage was noted in cells treated with 
E600. The dilation of rough endoplasmic reticulum seen in Wolman's 
disease cells may have~een due to the glutaraldehyde fixation procedure. 
The damage appeared to be slightly more severe in the Wolman's disease 
cells incubated in colloidal gold for 24 hr. 
Increased numbers of dense bodie~many containing crystalloid 
clefts, were obvious in E60D-treated cells. This supports the conclusion 
shown in Research Section II that E600-treated cells, because they show 
. 
increased numbers of neutral red granules, have an increased number of 
lysosomes. Although direct stimulation cannot be ruled out, it seems 
likely that this is caused indirectly and represents an attempt by the 
cells to clear the lipid accumulations induced by E600 treatment. 
The longitudinal filaments observed by SEM have the same morphology 
as actin stress fibers in human (109) and mouse (110) fibroblasts. 
Acti.n filaments are th~ught to be involved in the spreading of 
fibroblasts (Ill) and the maintenance of cell shape as well as such 
diverse and important processes as growth, adhesion to the substratum, 
and cellular motility (109). The apparent a1lignment of the E600-induced 
lysosomes along actin filaments supports the observation of linear neutral 
red granules that were particularly noticeable in the GM-2121 culture 
(Fig. 32). Although fixation and drying might cause organelles to 
line up against resisting structures like bundles of actin filaments, 
the apparent association of lysosomes and actin filaments in the 
unfixed neutral red stained cells makes it likely that this is not an 
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artifact of fixation. Actin has been shown in fibroblasts surrounding 
Ph:ago1ysosomes cOI1tain~ng latex beads. (112). An association between 
lysosomes and microfj.laments has been reported in polymorphonuclear 
leukocytes (113), by both TEM and SEM. It is tempt~ng to speculate 
that the contractile pro~ein actin may direct or at least modulate the 
\ 
intracellular movements of lysosomes. 
The clear perinuclear area visible by SEM and neutral red 
staini,ng of E600-treated cells was stained by the copper phthalocyanin 
procedure for phospholipids (Research Section'II). By TEM, little 
G~lgi was observed in this area. Lipid-containing lysosomes, which 
filled most of the cytoplasm, may have displaced other cell organelles 
to this area. This area did seem to show a s~ight increase in the 
..... 
concentration of r~ugh endoplasmic reticulum and mitochondria by 
TE~1 (:b~ig. 44). Perhaps the concentration of membrane in this area 
increased sufficiently to be visualized by the phospholipid staini.ng 
procedure. 
DISCUSSION 
Fibroblasts derived from a child with Wolman's disease exhibited 
a long #5 chromosome, but this find~ng was called into question when 
cells that had been stored frozen did not show the anomaly. If the 
initial finding was rep\esentative of the karyotype of the proband, a 
translocation probably occurred in the father's germ cells or in an early 
mitotic division of the zygote, resulti,ng in the deletion of the 
father's normal acid lipas~ gene and suggesting that the acid lipase 
gene locus may be on chromosome #5. If the initial karyotypic find~ng 
was an artifact of tissue culture, either individual variation in 
the father's acid lipase level and variation within the assay resulted 
in his not appearing to be a carrier, or the presumed father was 
not the true father of the child and the true father was a carrier 
for acid lipase deficiency. The different Wolman's disease cell 
cultures stored different amounts of lipid which may have depended 
on the rate of proliferation of the cell cultures. 
Normal cells treated with the esterase inhibitor E600 exhibited 
time dependent lipid storage that appeared maximal at lO~3M E600. 
The stored lipid appeared to be derived from serum lipid. As in 
Wolman's disease, triglycerides and cholesteryl esters accumulated. 
In addition, howe.ver, phospholipid storage and slightly increased 
free cholesterol and free fattY,acid storage were observed. Wolman's 
disease cells, which are deficient in acid lipase, after treatment with 
E60Q,showed comparable increases in all lipid classes but free fatty 
acid, imply~ng that E600 inhibited some enzyme activity present in 
Wolman's disease cells. The phospholipid storage suggested inhibition 
III 
of an additional en.zyme. E600-treated cells exhibited.reduced acid 
lipase activity, showing that acid lipase deficiency was probably 
partially responsible for the lipid storage. 
Ultrastructurally, Wolman's disease and E600-treated normal 
cells showed lipid clefts within dense bodies that were sometimes 
associated with colloidal gold particles. The E600-treated cells 
exhibited increased numbers of dense bodies and had increased neutral 
red granules by ~ight microscopy. 
When viewed by scann~ng electron microscope, Wolman's disease 
cells. resembled normal cells, but E600-treated cells showed bumps 
that appeared to represent structures arranged lineraly alo.ng actin 
filaments. A similar arrangement was s.ugge~ted by neutral red~Astainlng. 
Altho.ugh E600 was found to induce lipid sto~age in all tes ts, 
in the early experiments presented in much of Research Section II, 
-3 the optimum concentration appeared to be 10 M E600, whereas in later 
experiments, such as the. gas chroma~ography and electron microscopy, 
the optimum concentration appeared to be lO-4M E60D. In the later 
-3 experiments 10 M E600 was more toxic to the cells. There are two 
likely eh~lanations for this find~ng. E600-treatcd cells showed 
less toxicj.ty when grown on glass than when grown on polystyrene. 
In all the histochemical experiments the cells were grown o~ glass 
coverslips. For the' lipid biochemistry and electron w~croscopy 
however, the cells were grown in polystyrene flasks or culture dishes 
respectively. It is worthy of note that the relative toxicity and 
growth curve experiments, early experiments in which the cells were 
grown in polystyrene culture dishes, showed significant toxicity 
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at lO-3M E600. Perhaps the E600 binds to the plastic, presenting 
an increased local concentration where the cells are present. However, 
-4 there still appeared to be an increased effect of 10 M E600 on 
cells gro~~ on. glass coverslips in late experiments. Different 
lots of FCS were utilised in the early and late experiments. It 
is possible that the different lots varied in paraoxonase activity. 
If the FCS used in the later experiments had less paraoxonase activity, 
the treated cells would eA-perience an effective increase in the 
concentration of E600. 
The increase in phospholipid observed in E600-treated cells 
is difficult to interpret. Histochemically an increase in phospholipid 
staini.ng was visible in a perinuclear location, but ultrastruct:urally 
this area appeared essentially normal. If the increase were due to 
inhibition of a lysosomal phospholipase, the ~ipid would be expected 
to be stored in the lysosome ~d to be discernible by histochemical 
staining. If the storage were cytoplasmic or represented an increase 
in the amount of membz'ane, it would be difficult to detect histochemically. 
The major increase in membranes in E600-treated cells appeared to 
be due to a vast increase in the number of lysosomes. This may at 
least account for a part of the phospholipid increase. An increased 
number of lamellar bodies may also have accounted for some phospholipid 
storage. Because phospholipid degradation requires cleavage of glyceryl 
fatty acid esters and phosphate esters, it is quite possible that E600-
induced inhibition of a phospholipolytic enzyme is also involved. 
The evidence appears, good. tha t, as in Wolman t s disease, 
the storage of triglycerides and cholesteryl'esters in E600-treated 
cells occurs in lysosomes. Firstly, E60D inhibited acid lipase, a 
lysosomal enzyme. Acid lipase deficiency results in lysosomal lipid 
storage in Wolman's disease (16,101). Secondly, the cholestery1 
esters in both Wolman's disease and E600-treated cells had the same 
fatty acid pattern as ~holesteryl esters in FeS, suggesting that 
they had not been ~egraded. Since cholesteryl esters are normally 
taken up at receptor sites and transported to the 1ysosomes for 
degradation by acid lipase (9), the lack of degradation suggests 
that the deficiency of acid lipase resulted in the storage of the 
cholesteryl esters in the lysosomes. A third line of evidence that 
the stor.age of lipid in E600-treated cells is lysosomal is indicated 
by the morphology of the oil red 0 granules. In Wolman's disease 
.... , 
and E60D-treated cells, the granules were small and close to the 
nucleus. In contrast, cells treated with large amounts of free 
fatty acid or cholesterol stored the lipid in large droplets at 
the periphery of the cells. Because little lipid was seen in areas 
where the lysosomes were most abundant, lipid transported to these 
areas may have been degraded. A fourt·h line of evidence that the 
storage was lysosomal is the presence in E600-treated cells of a 
clear perinuclear zone surrounded by numerou~ granules that stained 
with oil red 0 and neutral red, appeared as bumps by SEM, and as 
dense bodies containing lipid clefts by !EM. The similar appearance 
of the clear zone suggests that these structures are identical 
and, because they stained with both oil red 0 and neutral red, that 
they represent lipid-containing lysosomes. As a fifth line of 
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evidence, the electron-dense structures that sometimes contained lipid 
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clefts by TEM could be shown to be associated with colloida~ gold 
particles, indicating that they were probably secondary lysosomes. 
In several animal model systems of atherosclerosis, cholesteryl 
esters have been shown to be stored in 1ysosomes of cells of the 
~ 
aortic wall (22,114,115). An accompanying increase was observed 
in lysosomal size (22,115), number (22,115) and activity (114). 
Increased lysosomal number and activity have also been reported 
in aortic smooth ml~cle cells of hypertensive rats (116). Aortic 
smooth muscle cells have acid lipase activity (15,23) and evidence 
indicates that this activity may be reduced in atherosclerosis (26,117,118) 
and hypertension (25). It has been proposed that a relative deficiency 
of acid cholesterol esterase (22-24) or acid esterase (25,26'~f7,ll8), 
which appear to be identical to acid lipase (13,15), may playa 
role in the pathogenesis of atherosclerotic disease. Autopsy findings 
from patients with acid lipase deficiency diseases, give support 
to this hypothesis. Arterial accumulation of fat is a typical finding 
in Wolman's disease (8). Advanced atherosclerosis has been seen in 
bwo of the three autopsies performed on patients with cholesteryl 
ester sto~age disease (5,7). 
Although aortic smooth muscle cells and fibroblasts in culture 
store little lipid, when treated with certain chemicals they can 
be induced to store cholesteryl esters and reproduce features of 
atherosclerotic cells. Cells treated with low density lipoprotein 
(LDL) modified to carry a strong positive cha,rge by a covalent linkage 
to N,N-dimethyl-l,3-propanediamine (DMPA) stored massive amounts 
of cholesteryl esters (119-121). The lipid droplets did not appear 
to be membrane limited in either fibroblasts. (120) or smooth muscle 
cells (121). DMPA-IDL appears to be a useful method of inducing 
non-lysosomal cholesteryl ester sto~age. Fibroblasts treated with 
25-hydroxycholesterol also appeared.to store cholesteryl esters 
in the cytoplasm (9,80,~22). Cytoplasmic esterification is normally 
stimulated by an increase in cytoplasmic cholesterol which suppresses 
the cholesterol synthetic pathway (9,80,122). This may result from 
the hydrolysis of cholesteryl esters in the lysosomes. Cytoplasmic 
hydrolysis of en~ogenously synthesized cholesteryl esters is not 
dependent on lysosomal acid lipase and occurs equally well in normal, 
choles'teryl ester sto~age disease, and chloroquine-treated cells 
(9) • 
Chloroquine treatment appears to induc'e lysosomal cholesteryl 
ester stor.age in fibroblast (9,80,120,123) and aortic smooth muscle 
(124) cultures, and its use has been proposed in a model system 
for studying the role of the lysosomal system in atherosclerosis 
(124). Chloroquine-induced cholesteryl ester storage probably results 
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from the inhibition of acid lipase (20,80) in keep~ng with the hypothesized 
role for acid lipase in the etio~ogy of atherosclerosis. However, 
chloroquine inhibits other lysosomal hydrolases involved in the 
degradation of mucopolysaccharides (125) and proteins (126). These 
results are tho.ught to stem from increases in the lysosomal pH (127). 
Chloroquine may have other complex actions on cells, i.ncluding inhibition 
of receptor-mediated endocytosis of lysosomal enzymes (45). Because 
E60o-induced accumulation of cholesteryl esters appears to be caused 
by specific inhibition of acid lipase whereas chloroquine-induced 
accumulation is.thought to result·from a.non-specific alteration 
of the intralysosomal environment, E600 may be more suitable for 
inducing lysosomal cholesteryl estersto~age as a means of studying 
atherosclerosis in vitro. 
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Chloroquine-indJced cholesteryl ester accumulation has been 
reporte~ to be maximal after 48 hr (124) and the cholesteryl ester 
accum~llation has not exceeded 102.0 .J.1glmg protein (123). E600-induced 
lipid accumulation thus results in greater ch.olesteryl ester accumulations 
th&~ chloroquine (Table 8) and the lipid continues to accumulate 
with time (~igs. 20~22), a situation that may be more analogous 
to the development of atherosclerosis. In addition, E600-trea ted 
cells exhibit increased numbers of lysosomes (Figs. 32,44) as ~s 
been observed in atherosclerosis (22,115).· This has not been shown 
in chloroquine-treated cells. The stored lipid, in chloroquine-
treated cells, is still bound to the protein component of LDL (9,80). 
In Wolman's disease, the protein appears to be degrad~ normally 
(10). Whether or not the chloresteryl ester stored in atherosclerosis 
or in E600-treated cells is ·still bound to protein is DOt presently 
known. 
There is much room for further research on Wolman's disease 
and E600-treated cells and on their relation to atherosclerosis. 
The major difference-between the lipids stored in Wolman's disease 
and E600-treated cells was the large increase in phospholipid storage 
after E600-treatment. Altho,ugh a preliminary separation of the 
phospholipid classes was carried out, further phospholipid analysis 
might prove reward~ng. Cells could be, grown in the presence of 
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E600 and ino,rganic phosphate with radiolabeled .phosphorus. After· 
extracting.the lipids and separat~ng the phospholipids by two dimensional 
thin layer chromatography, the phospholipid spots could be scraped 
from the plates, extracted from the silic~ gel, and the radioactivity 
measured on a liquid sc~tillationcounter. This experiment would 
give a more accurate numerical representation of the phospholipid 
classes stored in E600-treated cells. 
Chloroquine has been shown to inhibit lDL degradation for 
seven hr after its removal (80). It would be interest~ng to determine 
how long after removal of E600 the treated cells ~egin to hydrolyze 
the stored cholestel~l esters. Replicate culture dishes of cells, 
after grow~ng for 24 hr in lipoprotein deficient serum with or w~thout 
E600 J could be sv.Titched to a' medium containing cholesteryl ester-
LDL in which the cholesterol has been radiolabeled. At this time 
and every hr afterward, lipid could be extracted from duplicate 
dishes and separated by thin layer chromatography. The spots could 
be scraped, the lipid extracted, and the extent of radioactivity 
measured on a liquid scintillation counter. The total amount of 
free radiolabeled cholesterol would represent the cholesteryl esterolytic 
activity (9). The results of this experiment should show clearly 
at what time activity returns to E600-treated cells as well as 
demonstrating ,again that the E600 initially causes inhibition. 
Goldstein et ale (9) demonstrated that when substrate built 
,up sufficiently in cholesteryl ester sto~age disease cells, the 
monolayers showed 1/3 the activity of normal cells altho,ugh extracts 
from the cells .showed only 5% of . the normal activity. It i.s possible 
that the small difference present in acid lipase activity of Wolman's 
disease and cholesteryl ester sto~age disease cells may be ~agnified 
when increased substrate is presented to the enzyme in intact cells, 
result~ng in the extre,e difference in symptoms between the two 
diseases. This could be tested by grow~ng replicate culture dishes 
of cells (normal, cholesteryl ester .stor.age disease, and Wolman's 
disease) for 48 hr in lipoprotein deficient serum and then switching 
them to ~ growth medium containing cholesteryl ester-LDL in which 
the cholesterol has been radiolabeled. At this time and every hr 
aftervlard, duplicate culture dishes would be extracted and prepared 
as outlined in the experiment above. Not only might this experiment 
"" dist~nguish betwe.en cholesteryl ester stor_age disease and Wolman's 
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disease cells, but, if the Wolman's disease cells do show some residual 
acid lipase &ctivity, it ~ight explain why E600-treated Wolman's 
disease cells, in which residual acid lipase activi~ could be inhibited, 
stored additional t~iglycerides and cholesteryl esters. The effect 
of E600 could be tested in this system to determine if the residual 
acid lipase activity is truly inhibited. 
Cytoplasmic cholesteryl ester synthesis and hydrolysis have 
been shown ,to be normal in cholesteryl ester storage disease and 
chloroquine-treated cells (9). Because E600 inhibits esterase 
enzymes whereas chloroquine inhibits lysosomal degradat.ion, E600 
may well have an effect upon the cytoplasmic cholesteryl ester 
hydrolase and perhaps even the synthetase (fatty acyl-CoA:cholesteryl 
acyltransferase). The cytoplasmic cholesteryl ester hydrolase 
119 
may not be as resistant to E600 as acid lipase, so different E600 
concentrations should be evaluated. .It would also be interest~ng 
to compare cholesteryl ester sto~age disease and Wolman's disease 
cells, to determine if a difference in this system may account 
for the more serious na\ure of the latter disease. Normal, cholesteryl 
ester s tor,age disease and Wolman's disease cells, after incubation 
in lipoprotein deficient serum, .would be incubated in replicate culture 
dishes ltlith LDL and radiolabeled oleate with or without E600 for 
20 hr. This would label endogenously synthesized cholesteryl esters. 
The cells would be switched to lipoprotein deficient serum with or 
without E600. At this time and at intervals up to 24 hr, the 
cholesteryl oleate would be extracted from replicate dishes, separated 
..,;"\ 
by thin layer chromat,ography, and the amount of radioactivj.ty in 
the cholesteryl ester spots would be measured on a liquid scintillation 
counter. The decrease in cholesteryl ester radioactivity serves 
as a measure of cytoplasmic cholesteryl esterase activity and the 
initial level measures synthetase activity_ 
Because an increase in lysosome number was seen in E600-treated 
cells, it would be interesting to see if other event~ that have been 
reported in animal model systems of atherosclerosis also occur in 
E60o-treated cells. The activity of other lysosomal hydrolases in 
E600-treated cells should be tested to determine if similar increases 
to those seen in atherosclerotic cells (114) occur. In addition, 
studies of lysosomal phospholipases would be worthwhile. No increase 
in lysosomal size was noted by !EM in E600-treated cells, though 
authors have reported this in atherosclerosis model systems (22,115).· 
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Reduced lysosomal density due to lipid accumulation was reported 
in aortic cells in rabbit experimental atheroma (114). Because of 
the massive lipid sto~age, and the apparent involvement of lysosomes 
in E600-treated cells, a similar result ~ght be expected. This 
could be tested by dilferential cent~i~ugation to purify lysosomes 
and centrif,ugation in sucros~ gradients to determine the density 
of the lysosomes. 
In order to determine the importance of acid lipase in the 
etiology of atherosclerosis and how closely E600-treated cells resembled 
atherosclerotic cells it would be important to determine if the 
cholesteryl ester remains bound to the protein component of LDL 
as in chloroquine-treated cells (9,80) or if the pro~ein is degraded ... ~ 
normally as in cholesteryl ester storage disease (91'10) and Wolman's 
disease (10). If both protein and cho1esteryl ester degradation were 
inhibited, a general overloading of lysosomes with relative decreases' 
in proteolytic and cholesteryl e.sterolytic hydrolase a,ctivities would 
be indicated, whereas if only cholesteryl ester degra~ion were inhibited, 
a relative deficiency of acid lipase would be indicated. In an animal 
rendered atherosclerotic by cholesterol feeding, th,eaorta could be 
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removed and perfused with I-labeled LDL or cholesteryl ester-LDL 
with radiclabeled cholesterol. The ability of the tissue to degrade 
the LDL and cholesteryl esters could be compared to that of normal 
animals. For E600-treated cells in culture, after incubation of replicate 
culture dishes in lipoprotein deficient serum, the labeled LDL and 
E600 could be added. At this time and every hr after this, duplicate 
cultures would be extracted with trichloroacetic acid for 
125 . 
l~labeled 
acid soluble material (9,10,80) 'or with chloroform-methanol for 
radiolabeled free cholesterol (9,10) and the radioactivity measured 
on a liquid scintillation counter. 
The results reported here.s~ggest that E600 may be useful for 
load~ng cultured cells ~ith cholesteryl esters in order to study the 
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cleari:ng of cholesteryl esters accomplished by dlfferent pharmaco~ogica1 
,agents. Stein ~ ale (123,124) showed that medium enriched in ~igh 
density apolipoprotein and sph~ngomyelin.led to increased depletion 
of cellular cholesterol and cholesteryl ester in cells pretreated 
with chloroquine. E600 pretreatment could prove useful in similar 
experiments. A d~ug could also be tested for its ability to block 
IDL uptake by treati,ng cells in the presence of E600. If the dt::ug 
were effective, there would be a reduction in E600-induced lipid 
accumulation. E600 trea.tment could potentially be employed on any 
cell type which can be maintained in vitro. 
In addition, E60D might prove useful in assessing the role 
of acid lipase in the lysosomal ~igestion of more comp1ex substances 
and micro~rganisms, alth~ugh in p~gocytic cells E600 would probably 
inhibi.t other esterase enzymes as well as acid lipase. 
~ great deal of study remains to be done on acid lipase. The 
enzyme has not been purified nor has the: gene been mapped. Studies 
in this area may have important therapeutic consequences. Enzyme 
replacement therapy appears to be helpful in Fabry's disease and Gaucher's 
disease (128), two lipid storage diseases in which symptoms are not 
due to lipid accumulations in the central nervous system. To obtain 
sufficient acid lipase for enzyme replacement therapy would probably 
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requir~ genetic engineering utilizin.g.recombinaut DNA techniques. 
Once l~rge anlounts of purified acid lipase can be obtained, not only 
~ght enzyme replacement therapy be of use in treating patients with 
Wolman's disease and cholesteryl ester storage disease, but more importantly 
it might also permit th~ reduction of.atherosclerotic plaques, providing 
a safe and simple therapy for what is today the leading cause of death 
in the United States. 
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